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ABSTRACT 
The outstanding structural polymorphism of DNA allows for the formation of non-
canonical secondary structures, such as G-quadruplexes (G4s), G-triplexes (G3s) and i-
motifs. G4 and i-motif structures are found within important functional genomic regions such 
as telomeres and gene promoters. In particular, they are localized within the promoter regions 
of several proto-oncogenes, whose overexpression leads to malignant transformation, where 
they play a major role in the regulation of transcription. In many cases, the biological 
consequence of non-canonical secondary structure formation in the promoter element is gene 
silencing. For this reason, the search for ligands able to bind and stabilize G4s and/or i-motifs 
is pharmacologically very important to develop new anticancer strategies.  
In this PhD thesis, a series of studies have been carried out with the aim of investigating 
these non-canonical nucleic acid structures and their interaction with potential anticancer 
drugs. Such studies have led to the discovery of new and selective G4 ligands (Chapter 3). 
Chapter 4 deals with the tandem application of virtual screening along with experimental 
investigations, that led to discover the first dual G-triplex/G-quadruplex stabilizing 
compound. In Chapter 5, biophysical techniques have been employed to demonstrate that 
some well-known G4 ligands are also able to interact with i-motif structure. 
The last section of this PhD thesis deals with a study conducted in Dr. Vincenzo Abbate’s 
laboratory at King’s College London (UK). It concerns the design and synthesis of a new 
class of gallium chelator to be employed in the development of chemically-modified nucleic 
acid aptamers to be used as theranostics.  
 
 II 
 
LIST OF PUBLICATIONS 
Paper I 
“Toward the Development of Specific G‑Quadruplex Binders: Synthesis, Biophysical, and 
Biological Studies of New Hydrazone Derivatives”. J. Amato, R. Morigi, B. Pagano, A. 
Pagano, S. Ohnmacht, A. De Magis, Y. Tiang, G. Capranico, A. Locatelli, A. Graziadio, A. 
Leoni, M. Rambaldi, E. Novellino, S. Neidle, and A. Randazzo. J. Med. Chem., 2016, 59, 
5706-5720. doi: 10.1021/acs.jmedchem.6b00129. 
 
Paper II 
“Targeting the BCL2 Gene Promoter G-Quadruplex with a New Class of Furopyridazinone-
Based Molecules”. J. Amato, A. Pagano, D. Capasso, S. Di Gaetano, M. Giustiniano, E. 
Novellino, A. Randazzo, and B. Pagano. ChemMedChem, 2018, 13, 406-410. doi: 
10.1002/cmdc.201700749. 
 
Paper III 
“Tailoring a lead-like compound targeting multiple G-quadruplex structures”. J. Amato, C. 
Platella, S. Iachettini, P. Zizza, D. Musumeci, S. Cosconati, A. Pagano, E. Novellino, A. 
Biroccio, A. Randazzo, B. Pagano, and D. Montesarchio. Eur. J. Med. Chem. 2019, 163, 295-
306. doi: 10.1016/j.ejmech.2018.11.058. 
 
Paper IV 
“Discovery of the first dual G-triplex/G-quadruplex stabilizing compound: a new opportunity 
in the targeting of G-rich DNA structures?”. J. Amato, A. Pagano, S. Cosconati, G. 
Amendola, I. Fotticchia, N. Iaccarino, J. Marinello, A. De Magis, G. Capranico, E. Novellino, 
B. Pagano, A. Randazzo. Biochimica et Biophysica Acta – General Subjects, 2017, 1861, 
1271-1280. doi: 10.1016/j.bbagen.2016.11.008. 
 
 III 
 
 
Paper V 
“Common G-Quadruplex Binding Agents Found to Interact With i-Motif-Forming DNA: 
Unexpected Multi-Target-Directed Compounds”. A. Pagano, N. Iaccarino, M. A. S. 
Abdelhamid, D. Brancaccio, E. U. Garzarella, A. Di Porzio, E. Novellino, Z. A. E. Waller, 
B., J. Amato, and A. Randazzo. Frontiers in Chemistry, 2018, 6, 281. doi: 
10.3389/fchem.2018.00281. 
 
 
Other publications 
1. “Characterization of monovarietal extra virgin olive oils from the province of Béjaïa 
(Algeria)”. F. Laincer, N. Iaccarino, J. Amato, B. Pagano, A. Pagano, G. Tenore, A. 
Tamendjari, P. Rovellini, S. Venturini, G. Bellan, A. Ritieni, L. Mannina, E. 
Novellino, and A. Randazzo. Food Research International, 2016, 89, 1123-33. doi: 
10.1016/j.foodres.2016.04.024. 
2.  “1H NMR-based metabolomics study on follicular fluid from patients with 
PolyCystic Ovarian Syndrome (PCOS)”. N. Iaccarino, J. Amato, B. Pagano, A. 
Pagano, L. D’Oriano, C. Alviggi, A. Randazzo. Biochimica Clinica, 2018, 42, 26-31. 
doi: 10.19186/BC_2018.008. 
 IV 
 
LIST OF ABBREVIATIONS 
A Adenine 
AMD Age-related macular degeneration 
BCL2 B-cell lymphoma-2 
BJ Human fibroblasts 
BJ-hTERT Human immortalized BJ fibroblasts 
C Cytosine 
CD Circular dichroism 
CPG Controlled pore glass 
CTCF Corrected total cell fluorescence 
DAPI 4’,6-diamidino-2-phenylindole 
DDR DNA damage response 
DEAD Diethyl azodicarboxylate 
DIPEA N,N-Diisopropylethylamine 
DMEM Dulbecco’s modified eagle medium 
DMF Dimethylformamide 
DMSO Dimethyl sufoxide 
DMT 4,4'-dimethoxytrityl 
DNA Deoxyribonucleic acid 
DSC Differential scanning calorimetry 
FACS Fluorescence activated cell sorting 
FAM 6-carboxyfluorescein 
FBS Fetal bovine serum 
FID Fluorescent intercalator displacement 
FP Furo[2,3-d]pyridazin-4(5H)-ones 
FRET Fluorescence resonance energy transfer 
G Guanine 
G3 G-triplex 
G4 G-quadruplex 
 V 
 
GE Gel electrophoresis 
HATU 1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-
b]pyridinium 3-oxid hexafluorophosphate 
HDF Normal human dermal fibroblasts 
HeLa Human adenocarcinoma cancer cell line 
HepG2 Human liver cancer cell line 
HIF-1α Hypoxia-inducible factor 1-alpha 
hTERT Human telomerase reverse transcriptase 
IF Immunofluorescence 
INS Insulin gene 
IR Infrared 
LCAA Long chain alkylamine 
MCF-7 Breast cancer cell line 
MST Microscale thermophoresis 
MTT Thiazolyl blue tetrazolium bromide 
NHE Nuclease hypersensitive elements 
NMR Nuclear magnetic resonance 
PAGE Polyacrylamide gel electrophoresis 
PBS Phosphate buffered saline 
PDGFR Platelet-derived growth factor receptors 
PET Positron emission tomography 
PI Propidium iodide  
POT1 Protection of telomere 1 
PSMA Prostate-specific membrane antigen 
PVDF Polyvinylidene fluoride 
qPCR Quantitative polymerase chain reaction 
RAP1 Repressor/activator protein 1 
RNA Ribonucleic acid 
RT-PCR Reverse transcriptase-polymerase chain reaction 
SDS Sodium dodecyl sulfate 
T Thymine 
TAMRA 6-carboxytetramethylrhodamine 
TBA Thrombin binding aptamer  
TCA Trichloroacetic acid 
 VI 
 
TEA Triethylamine 
TFA Trifluoroacetic acid 
THP Tris(hydroxypyridinone) 
TIF Telomere induced foci 
TIN2 TRF1- and TRF2-interacting nuclear protein 2 
TO Thiazole orange 
TPP1 Tripeptidyl peptidase 1 
TRF1 Telomere repeat factor 1 
TRF1 Telomeric repeat-binding factor 1 
TRF2 Telomere repeat factor 2 
TSS Transcription start sites 
U Uracile 
U2OS  Human bone osteosarcoma epithelial cell lines 
VEGF Vascular endothelial growth factor 
VS Virtual screening 
 
  
TABLE OF CONTENTS 
 
ABSTRACT ................................................................................................ I 
LIST OF PUBLICATIONS .............................................................................. II 
LIST OF ABBREVIATIONS .......................................................................... IV 
CHAPTER 1 INTRODUCTION ........................................................................ 1 
1.1 General description of nucleic acids ............................................................... 1 
1.2 Non-canonical nucleic acid structures ............................................................ 3 
1.2.1 G-quadruplexes ...................................................................................... 4 
1.2.2 G-triplex ................................................................................................ 7 
1.2.3 i-Motif ................................................................................................... 8 
1.3 Biological relevance of G-quadruplexes........................................................10 
1.3.1 Targeting G4 structure in cancer cells....................................................12 
1.4 Biological relevance of i-motif .....................................................................15 
1.5 DNA sequences as therapeutic agents ...........................................................16 
CHAPTER 2 METHODS ............................................................................... 19 
2.1 Circular dichroism ........................................................................................19 
2.2 Fluorescence Spectroscopy ...........................................................................21 
2.3 Electrophoresis .............................................................................................23 
2.4 Differential scanning calorimetry ..................................................................24 
2.5 Nuclear Magnetic Resonance ........................................................................27 
2.6 Microscale Thermophoresis ..........................................................................32 
CHAPTER 3 TARGETING G-QUADRUPLEXES ................................................. 35 
3.1 New Hydrazone derivatives as specific G-quadruplex binders (Paper I) .......37 
3.1.1 Introduction...........................................................................................37 
3.1.2 Results and discussion ...........................................................................38 
3.1.3 Conclusions ..........................................................................................55 
3.1.4 Experimental Section ............................................................................56 
3.2 Targeting the BCL2 Gene Promoter G-Quadruplex with a New Class of 
Furopyridazinone-Based Molecules (Paper II) ...............................................62 
3.2.1 Introduction...........................................................................................62 
  
3.2.2 Results and discussion .............................................................................. 66	
3.2.3 Conclusions .............................................................................................. 76	
3.2.4 Experimental Section ............................................................................... 76	
3.3 Tailoring a lead-like compound targeting multiple G-quadruplex .................. 81	
3.3.1 Introduction .............................................................................................. 81	
3.3.2 Results and discussion .............................................................................. 82	
3.3.3 Conclusions ............................................................................................ 101	
3.3.4 Experimental section .............................................................................. 102	
CHAPTER 4 TARGETING G-TRIPLEX ........................................................... 109	
4.1 Discovery of the first G-triplex/G-quadruplex stabilizing compound (Paper IV)
 ......................................................................................................................... 109	
4.1.1 Introduction ............................................................................................ 109	
4.1.2 Results and discussion ............................................................................ 111	
4.1.3 Conclusions ............................................................................................ 126	
4.1.4 Experimental Section ............................................................................. 126	
CHAPTER 5 TARGETING I-MOTIF-FORMING DNA ....................................... 133	
5.1 Common G-quadruplex binding agents found to interact with i-motif-forming 
DNA (Paper V) ............................................................................................... 133	
5.1.1 Introduction ............................................................................................ 133	
5.1.2 Results .................................................................................................... 135	
5.1.3 Discussion .............................................................................................. 148	
5.1.4 Conclusions ............................................................................................ 151	
5.1.5 Experimental Section ............................................................................. 152	
CHAPTER 6 SYNTHETIZING A NEW THP DERIVATIVE SUITABLE FOR THE 
CONJUGATION TO NUCLEIC ACID SEQUENCES ......................................... 156	
CONCLUSIONS ......................................................................................... 169	
REFERENCES ........................................................................................... 170	
APPENDIX ............................................................................................... 183	
 
 1 
 
Chapter 1 
INTRODUCTION 
 
1.1 General description of nucleic acids 
Nucleic acids are the biological macromolecules that play fundamental roles in cells and 
ensure the normal development and functioning of an organism. They are composed of 
nucleotides, which are monomers made of three components: a pentose sugar, a phosphate 
group and a nitrogenous base. If the sugar is a ribose, the polymer is ribonucleic acid (RNA); 
if the sugar is a deoxyribose, the polymer is deoxyribonucleic acid (DNA). The bases of DNA 
divide into two groups: purines [adenine (A) and guanine (G)] and pyrimidines [thymine (T) 
and cytosine (C)]. In RNA, thymine is replaced by uracil (U). Purines are made of six- and five-
membered nitrogen-containing rings fused together; pyrimidines consist of only a six-
membered nitrogen-containing ring (Voet and Voet, 1995) (Figure 1.1). 
 
 
Figure 1.1. Structure of purine and pyrimidine bases. 
 
A nucleoside is a molecule whose C1’ of the pentose sugar is covalently bound by an N-
glycosidic bond to the N9 or N1 of purines or pyrimidines, respectively. The rotations of this 
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glycosidic bond allows structural diversity to the DNA molecule. The glycosidic bond may be 
either syn or anti (Figure 1.2). 
 
 
Figure 1.2. The glycosidic bond: A) anti conformation; B) syn conformation. 
 
The syn conformation is formed when the C1’-O4’ bond is cis to the N9-C4 purine bond, 
and cis to the N1-C2 of pyrimidine. This occurs when the bulk of the purine base faces the sugar 
or when the C2 carbonyl is on top of the sugar ring. The anti conformation is formed when the 
bulk of the base is rotated away from the sugar. This occurs when the C1’-O4’ bond of the sugar 
is trans to the N9-C4 bond of the purine base. In pyrimidines, the anti conformation is formed 
when the C2 carbonyl faces away from the sugar. This occurs when the C1’-O4’ bond is trans 
to the N1-C2 pyrimidine bond. The attachment of a phosphate group to the C5’ carbon of the 
sugar converts a nucleoside into a nucleotide. A 5’-phosphate group of a nucleotide links to the 
3’-hydroxyl group of the next nucleotide to form a phosphodiester bond. The connected 
nucleotides by phosphodiester bonds form single-stranded DNA. 
The single-stranded DNA bases may pair non-covalent interactions, as first described for B-
DNA by Watson and Crick back in 1953. (Watson and Crick, 1953). Adenine and thymine 
(A:T) base pairs are held together by two hydrogen bonds, whereas guanine and cytosine (G:C) 
base pairs are held by three hydrogen bonds (Figure 1.3). 
 
      
Figure 1.3. Watson and Crick base pairs. 
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Thus, all four base pairs fit neatly into the double helix. The two strands are antiparallel, 
with the 5′-end of one strand adjacent to the 3′-end of the other. The two strands coil around 
each other to form a right-handed double helix, with the base pairs in the center and the sugars 
and negatively charged phosphates forming the external hydrophilic backbone. The stability of 
the duplex derives from both base stacking and hydrogen bonding. The B-DNA has a wide 
major groove and a narrow minor groove running around the helix along the entire length of 
the molecule (Figure 1.4). Proteins interact with the DNA in these grooves (principally in the 
major groove), and some small drug molecules (e.g. netropsin and distamycin) bind in the minor 
groove. 
 
Figure 1.4. DNA fragment in the B-form. 
1.2 Non-canonical nucleic acid structures 
Under certain conditions, nucleic acids can adopt non-canonical conformations other than 
B-DNA. These unusual DNA structures can involve from one to four nucleic acid strands, that 
may arrange into hairpins, cruciform, parallel-stranded duplexes, triplexes (H-DNA), G-
quadruplex (G4), i-motif and other non B-forms (Figure 1.5). It has been demonstrated that 
these structures are widely distributed throughout the human genome, and are enriched critical 
regions (Bacolla and Wells, 2009). In addition, their formation depends on the specific DNA 
sequence.  
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Figure 1.5. Schematic illustration showing some examples of non-canonical DNA structures. 
 
1.2.1 G-quadruplexes 
One of the most important non-canonical nucleic acid structures is the G-quadruplex (G4). 
It is a four-stranded structure formed by G-rich sequences, either DNA or RNA, which has at 
least two stacked G-tetrads (Majima and Tetsuro, 2011; Wang and Vasquez, 2006; Wells et al., 
2005; Zhao et al., 2010). A G-tetrad is a planar square arrangement of four guanines held 
together by eight Hoogsteen hydrogen bonds (Huppert, 2010; Rhodes and Lipps, 2018). In it, 
the N7 and O6 of each guanine are hydrogen-bond acceptors from N2 and N1 of adjacent one, 
respectively. The π-π stacking between the G-tetrads further stabilizes this structure. The G-
tetrads are linked by loops that can assume different conformations. Moreover, this arrangement 
delimits a central channel. 
The formation and stability of G4s strongly depends on cations, with the central channel 
neutralizing the strong negative electrostatic potential from guanine O6 atoms (Figure 1.6) 
(Bochman et al., 2012; Burge et al., 2006; Williamson et al., 1989). 
 
Figure 1.6. G-tetrad with monovalent cation [adapted from (Bochman et al., 2012)].  
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Cations that better stabilize the G4 structures are Na+ and K+. The precise location of the 
cations depends on their nature: Na+ ions are usually in-plane with the G-tetrads, while K+ ions 
are always equidistant between two G-tetrads, forming a symmetric tetragonal bipyramidal 
configuration with the oxygen atoms. Switching between Na+ and K+ often induces a structural 
alteration of G4s, which indicates high conformational flexibility for these structures (Burge et 
al., 2006). From a biological point of view, the K+ is far more biologically relevant due to its 
higher intracellular concentration (~ 140 mM) compared to Na+ (5-15 mM).  
The topology and stability of G4s depend on many factors: length and composition of the 
G4-forming sequence, strand stoichiometry and alignment, size of the loops, and nature of the 
binding cations.  
G4s can be unimolecular, when a single strand folds back on itself; bi- or tetra-molecular, 
when formed by two or four strands, respectively (Figure 1.7) (Huppert, 2010). 
 
 
Figure 1.7. Schematic representation of A) tetrameric, B) dimeric and C) monomeric G4 structures. 
 
G4s can be divided into four groups according to the relative strands orientation (Patel et al., 
2007; Phan, 2010): 
o Parallel-stranded core, in which four strands are oriented in the same direction (Figure 
1.8A); 
o Hybrid or (3+1) core, in which three strands are oriented in one direction and the fourth 
in the opposite direction (Figure 1.8B); 
o Antiparallel-stranded core, in which two strands are oriented in one direction and the 
other two in the opposite one, with an up-up-down-down core (Figure 1.8C); 
o Antiparallel-stranded core, in which two strands are oriented in one direction and the 
other two in the opposite one, with an up-down-up-down core (Figure 1.8D). 
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Figure 1.8. A) Parallel-stranded core; B) hybrid core; C) up-up-down-down core; D) up-down-up-down core 
[adapted from (Phan, 2010)]. 
 
Guanines in a G-tetrad may have two conformations: anti and syn. All parallel G4s have all 
the guanine glycosidic angles in the anti conformation, whereas antiparallel and hybrid G4s 
have both syn and anti.  
G-tetrads are linked by loops, which can be classified in four groups (Bugaut and 
Balasubramanian, 2008): 
o Lateral loop, connecting two adjacent antiparallel strands (Figure 1.9a); 
o Diagonal loop, connecting two opposing antiparallel strands across the G4 plane (Figure 
1.9b); 
o Double-chain-reversal loop or propeller loop, connecting two adjacent parallel strands 
(Figure 1.9c); 
o V-shaped loop, connecting two corners of a G-tetrad core in which a support column is 
missing (Figure 1.9d). 
 
 
Figure 1.9. Schematic illustration showing (a) lateral loop; (b) diagonal loop; (c) propeller loop; (d) V-
shaped loop [adapted from (Patel et al., 2007)]. 
 
Loops are usually short (1-7 nucleotides) and smaller loops result in more stable G4s (Bugaut 
and Balasubramanian, 2008; Gros et al., 2010). 
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All G4s have four grooves, which are the cavities delimited by the phosphodiester backbone. 
Groove dimensions vary and depend on the G4 overall topology and loops nature. If all strands 
are parallel, guanine angles are in the anti conformation, and the grooves are identical and 
medium-sized. If the glycosidic bonds orientations of the bases are syn-syn-anti-anti, two 
grooves are medium-sized, one narrow-sized and one wide-sized (Figure 1.10A). Finally, if the 
glycosidic bonds orientations of the bases are syn-anti-syn-anti, two grooves are narrow and 
the other two ones are wide (Figure 1.10B) (Burge et al., 2006).  
Several studies have shown that in particular regions of the genome, G-rich sequences can 
form unimolecular G4s in cell (Biffi et al., 2013; Lipps and Rhodes, 2009). In contrast to 
bimolecular and tetramolecular G4s, intramolecular structures can be formed quickly and are 
more complex due to great conformational diversity, such as in folding topologies and loops 
conformations (Yang and Okamoto, 2010). 
 
 
Figure 1.10. A) syn-syn-anti-anti glycosidic bonds orientation; B) syn-anti-syn-anti glycosidic bonds 
orientation. 
 
1.2.2 G-triplex 
Recent studies revealed that the folding and unfolding pathways of G4s proceed through a 
quite stable intermediate named G3. A G3 structure differs from the known triplex structures 
not only for the base pairing, but also for the structure. Indeed, this structure is characterized 
by the presence of G:G:G triad planes stabilized by an array of Hoogsteen-like hydrogen bonds 
similar to G4s. However, the lower number of hydrogen bonds and the smaller stacking surface 
of the triads with respect to the G-tetrads, make G3s much less stable than G4s and, therefore, 
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even more challenging to isolate both in vitro and in vivo. For all these reasons, it is clear that 
the discovery of molecules able to interact and stabilize G3s is highly appealing, also for the 
understanding of the putative biological and therapeutic importance of these intermediates. 
Recent studies allowed to isolate and characterize a G3 structure in details. In particular, it 
was demonstrated that a truncated form of the G4-forming thrombin binding aptamer (TBA) 
forms a relatively stable G3. (Limongelli et al., 2013). This structure has two G-triads 
(G1:G6:G10 and G2:G5:G11 Figure 1.11A), characterized by a syn-anti-syn and anti-syn-anti 
arrangement of the residues, respectively. In this conformation, the metal ion seems to be placed 
at the center of the two G-triads in a way similar to that of the G4 structure (Figure 1.11B).  
 
 
Figure 1.11. A) G‐triads involved in the formation of the G‐triplex; B) 3D representation of the G‐triplex 
[adapted from (Limongelli et al., 2013)]. 
 
1.2.3 i-Motif 
In 1993 Gehring, Leroy and Guéron observed that cytosine rich sequences can form four 
stranded structures under acidic conditions (Gehring et al., 1993). They found the d(TCCCCC) 
oligomer to form a four-stranded structure under acidic pH, two base-paired parallel-stranded 
duplexes are intimately associated and, fully intercalated. The relative orientation of the 
duplexes is antiparallel, so that each base pair is face-to-face with its neighbors (Figure 1.12). 
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Figure 1.12. (a) Structure of the intermolecular i-motif formed by d(TC5) (PDB ID: 225D), identified by 
Gehring et al. (b) Top view of the i-motif formed by d(TC5). (c) A hemiprotonated cytosine–cytosine+ base 
pair [adapted from (Day et al., 2014)]. 
 
Due to the unusual nature of the configuration, they called this new non-canonical nucleic 
acid structure intercalated (i) motif. Sequences with two stretches of cytosines can also form 
dimeric i-motif structures where two hairpins intercalate (Pairs et al., 1997); and, more 
interestingly from a biological perspective, natural sequences with four stretches of cytosines 
separated by other bases can fold into intramolecular i-motif structures (Figure 1.13).  
 
 
Figure 1.13. Schematic representation of tetrameric (A), dimeric (B) and monomeric i-motif structures (C). 
The yellow spheres represent the cytosines, plus signs indicate the protonated cytosines. 
 
There are two different i-motif topologies depending on the intercalation: i) the 3’E, in which 
the outermost cytosine pair is from the 3’ end; ii) the 5’E, where the outermost pair is from the 
5’ end (Guéron and Leroy, 2000; Nonin-lecomte and Leroy, 2001), and iii) the less stable T-
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form, which features non-intercalated outermost C-C+ pair (Kanaori et al., 2001). The 
intramolecular i-motifs have also been classified according to the length of the loops (Brooks 
et al., 2010): ‘class I’ i-motifs have shorter loops, whereas ‘class II’ i-motifs have longer loops. 
In general, ‘class II’ i-motifs are thought to be the more stable due to extra stabilizing 
interactions within the longer loop regions. 
As the formation of an i-motif requires the cytosine hemiprotonation, this structure is formed 
and is stable in vitro only under slightly acidic conditions (Zhou et al., 2010). However, it has 
been demonstrated that the negative superhelicity induced by transcriptional activity (Sun and 
Hurley, 2009), and cell-mimicking molecular crowding conditions (Rajendran et al., 2010) 
facilitate i-motif formation. 
1.3 Biological relevance of G-quadruplexes 
During the last decade, G4s have emerged from being a structural curiosity observed in vitro 
to being recognized as possible regulators of multiple biological processes. The sequencing of 
many genomes has revealed that they are rich in motifs with the potential to form G4s and that 
the location of those motifs is non-random, correlating with functionally important genomic 
regions.  
The evidence of G4s formation in cell was first observed in the telomeric region, which is at 
the end of the eukaryotic chromosomes. The first evidence was obtained using a specific 
antibody for intermolecular telomeric G4 DNA of the ciliate Stylonychia lemnae (Schaffitzel et 
al., 2001). Further evidence was achieved observing that telomere end-binding proteins control 
the formation of G4 DNA structures in vivo (Paeschke et al., 2005). Bioinformatic sequence 
analyses have also showed that such putative G4-forming sequences are present in the genome 
of different organisms (Rawal et al., 2006; Todd et al., 2005). There is an estimate of ~700000 
potential G4-forming sequences in the human genome (Chambers et al., 2015). 
The telomeric structure and stability directly relate to aging (Bodnar et al., 1998), genome 
stability (Hackett et al., 2001), and cancer growth (Neidle and Parkinson, 2002). Human 
telomeric DNA comprises a long stretch of double-stranded tandem repeats and a short, single-
stranded (TTAGGG)n 3’-overhang (Hemann and Greider, 1999; Zakian, 1995). It has been 
demonstrated that truncations of this G-rich sequence can form G4 structures in vitro by X-ray 
crystallography and nuclear magnetic resonance (Parkinson et al., 2002; Phan et al., 2007b; 
Wang and Patel, 1993; Williamson et al., 1989; Zhang et al., 2010).  
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Telomeres regulate cell senescence as they progressively shorten at each replication round 
until apoptosis is triggered by genomic instability (Sfeir et al., 2005). Telomerase is the 
ribonucleoprotein complex with reverse transcriptase activity that elongates telomeres (Greider 
and Blackburn, 1985). Due to overactivation, it is responsible for cell “immortalization” in 80-
85% of all human cancer (Kim et al., 2011). Telomerase recognizes the single-stranded 
telomeric DNA, but not the G4 structure. Therefore, the discovery of telomeric G4 ligands 
could be a way to induce the apoptosis in cancer cells. Furthermore, telomeric DNA also binds 
many other proteins like the shelterin complex. This complex is composed by six subunits: the 
telomere repeat factor 1 (TRF1), telomere repeat factor 2 (TRF2), protection of telomere 1 
(POT1), repressor/activator protein 1 (RAP1), TRF1- and TRF2-interacting nuclear protein 2 
(TIN2), and tripeptidyl peptidase 1 (TPP1). They can operate in subsets to regulate the length 
of or protect telomeres. In this context, small molecules competing with these proteins for the 
binding to the telomeric DNA would induce a DNA damage response, that quickly promotes 
senescence in cancer cells. 
Other regions of genome that are particularly enriched in putative G4 motifs are the gene 
promoters (~1 kb upstream of transcription start sites - TSS). G4s within gene promoters are 
now proved to regulate transcription (Huppert and Balasubramanian, 2007; Patel et al., 2007). 
The first evidence supporting the existence of unusual DNA forms in gene promoters dates 
back to 1982, and it is based on the nuclease hypersensitivity element (NHE) in the chicken β-
globulin gene promoter (Larsen and Weintraub, 1982; Wood and Felsenfeld, 1982), that was 
only later associated with guanine runs.  
G4s have been reported within the promoter of several genes, e. g. INS (Hammond-kosack 
et al., 1992), MYC (Siddiqui-Jain et al., 2002; Simonsson et al., 1998), VEGF (Sun et al., 2005), 
HIF-1α (Armond et al., 2005), BCL-2 (Dai et al., 2006), KIT (Fernando et al., 2006; Rankin et 
al., 2005), RET (Zhou et al., 2010), PDGF-A (Qin et al., 2007), and KRAS (Cogoi et al., 2004). 
In 2008, Du et al. performed a comprehensive analysis of the relationship between potential G4 
DNA motifs in the putative transcriptional regulatory region and gene expression level (Du et 
al., 2008). The MYC oncogene is a transcription factor that regulates the expression of a variety 
of genes and it is one of the most prevalent oncogenes found to be altered in human cancer, 
being dysregulated in about 50% of tumors (Delgado et al., 2013). The transcriptional 
regulation of MYC is tightly controlled by a complex mechanism involving four promoters (P1–
P4), different transcription start sites (TSS) and nuclease hypersensitive elements (NHE). In 
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particular, the NHE III1, located just upstream the promoter P1 is responsible for the great 
majority of MYC transcription. It is composed of five consecutive runs of the sequence 
(G/A)G(G/A)AGGGGT that can form a G4 structure (González and Hurley, 2010). As a 
consequence, the possibility to inhibit MYC transcription through G4 stabilization has been 
actively pursued in several human cancer models using specific small molecules (González and 
Hurley, 2010). 
A number of G4 structures from gene promoters has been determined by X-ray or NMR 
techniques (Ambrus et al., 2005; Hsu et al., 2009; Wei et al., 2012). In contrast to the tandem 
repeats in human telomeres, the G-rich sequences within gene promoters are often composed 
by G-tracts with an unequal number of guanines and a varying number of intervening bases. 
Each of these promoter sequences is unique in length, and type of G-tracts, and intervening 
bases (Qin and Hurley, 2008) and can form multiple G4s, i. e. mixtures of conformations.  
Notably, G4s from promoters exhibit the highly conserved G3NG3 motifs, which forms a 
robust parallel-stranded structure with a 1-nt, double-chain-reversal loop (Yang and Okamoto, 
2010) (Figure 1.14). 
 
Figure 1.14. Comparison of G4-forming sequences in selected gene promoters. The telomeric sequence is 
also shown as a comparison. All the promoter G-rich sequences shown contain the G3NG3 motif; except for 
the BCL-2 (Bcl2Mid) sequence, they have all been shown to form parallel-stranded G-quadruplexes. 
 
1.3.1 Targeting G4 structure in cancer cells 
Considering the crucial position of G4s in the genome and their important role in the 
carcinogenic processes, targeting them with small molecules could be a potential anticancer 
approach. In the last decade, a huge number of small molecules has been studied to evaluate 
their ability to stabilize G4 structures. 
The natural product Telomestatin (Figure 1.15A) has been identified as a potent telomeric 
G4 stabilizer (Sun et al., 1997). It competes POT1 for the binding to the telomeric G4 DNA 
triggering DNA damage response and cellular senescence (Gomez et al., 2006; Temime-Smaali 
 13 
 
et al., 2009). The same effect has been also observed for a panel of other G4-interacting small 
molecules. The triazine 12459 (Figure 1.15B) induces telomere shortening by POT1 uncapping, 
leading to cellular senescence (Gomez et al., 2003; Riou et al., 2002). The acridine BRACO-
19 (Figure 1.15C), one of the very first promising synthetic G4-targeting small molecules, is a 
very potent telomerase inhibitor (Gunaratnam et al., 2007). RHPS4 and Pyridostatin (Figure 
1.15D-E) induce telomere uncapping leading to a telomere-induced DNA damage response 
(Leonetti, 2004; Phatak et al., 2007; Rodriguez et al., 2008; Salvati et al., 2007). 
 
 
Figure 1.15. Structure of (A) Telomestatin, (B) 12459, (C) BRACO-19, (D) RHPS4, and (E) Pyridostatin. 
 
Therefore, small molecules that bind and stabilize these structures are generally able to 
inhibit the telomerase thereby triggering DNA damage responses as with other mediators of 
telomere damage (d’Adda di Fagagna et al., 2003). 
G4s could be also the potential targets in a new anticancer strategy based on search for G4-
selective stabilizing ligands aimed at inhibition of oncogenes expression (Balasubramanian et 
al., 2011) (Figure 1.16). 
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Figure 1.16. Scheme representing the targeting of a G4 to suppress oncogene transcription. 
 
For example, it has been proved that the cationic porphyrin derivate TMPyP4 (Figure 1.17) 
can downregulate the prominent oncogene MYC by stabilizing a G4 structure in its promoter 
(Siddiqui-Jain et al., 2002). Interestingly, a G > T mutation in the G4-forming sequence within 
the MYC promoter sufficed to destabilize the G4 and resulted in increased transcription, which 
was only partially reduced by TMPyP4. 
 
 
Figure 1.17. Chemical structure of TMPyP4. 
 
Another example of proto-oncogene with a G4-forming sequence within this promoter is 
KIT gene, which encodes for a tyrosine protein kinase (Fernando et al., 2006; Rankin et al., 
2005). It was demonstrated that 3,8,10-trisubstituted isoalloxazines stabilize G4s in the KIT 
promoter and inhibit its expression (Bejugam et al., 2007). 
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1.4 Biological relevance of i-motif 
As yet, there has been no systematic analysis of the genome to find sequences capable of forming 
i-motifs. Due to the complementary nature of putative G4 and i-motif forming sequences, it is likely 
that there is some overlap in their prevalence. However, the stability and the dynamics of i-motif 
structures are likely to vary a lot, depending on the sequence. Initial investigations on natural i-
motif forming sequences focused on those from the complementary C-rich strands of known 
promoter G4-forming sequences. A range of i-motif forming sequences has now been identified 
and characterized (Table 1.1). 
 
Table 1.1. Examples of investigated i-motif forming sequences [adapted from (Day et al., 2014)]. 
Name Sequence 5’→ 3’ 
hTelo d(CCCTAACCCTAACCCTAACCCT) 
c-MYC d(CCCCACCTTCCCCACCCTCCCCACCCTCCCC) 
bcl-2 d(CAGCCCCGCTCCCGCCCCCTTCCTCCCGCGCCCGCCCCT) 
Rb d(GCCGCCCAAAACCCCCCG) 
RET d(CCGCCCCCGCCCCGCCCCGCCCCTA) 
VEGF-A d(GACCCCGCCCCCGGCCCGCCCCGG) 
c-ki-ras d(GCTCCCTCCCTCCCTCCTTCCCTCCCTCCC) 
c-kit d(CCCTCCTCCCAGCGCCCACCCT) 
PDGF-A d(CCGCGCCCCTCCCCCGCCCCCGCCCCCGCCCCCCCCCCCCC) 
c-myb d(TCCTCCTCCTCCTTCTCCTCCTCCTCCGTGTCCTCCTCCTCC) 
hTERT d(CCCCGCCCCGTCCCGACCCCTCCCGGGTCCCCGGCCCAGCCCCCACCGGGCCCTCCCAGCC
CCTCCCC) 
HIF-1 α d(CGCGCTCCCGCCCCCTCTCCCCTCCCCGCGCGCCCGAGCGCGCCTCCGCCCTTGCCCGCCCC
CTG) 
c-jun d(TAACCCCCTCCCCCTCCCCCCTTTAAT) 
ILPR d(TGTCCCCACACCCCTGTCCCCACACCCCTGT) 
n-MYC d(ACCCCCTGCATCTGCATGCCCCCTCCCACCCCCT) 
 
 
Furthermore, some proteins have been identified to bind C-rich stands in human telomeres 
with specificity (Day et al., 2014). 
As for putative i-motif forming sequences in gene promoter regions, the NH3 III1 of MYC 
proto-oncogene contains a C-rich strand capable of forming an i-motif. Another oncogene 
promoter that has a C-rich sequence prone to form i-motif is the P1 promoter of the B-cell 
lymphoma-2 (BCL-2) proto-oncogene. Unlike other proto-oncogenes, BCL-2 promotes cell 
survival and proliferation via an anti-apoptotic function rather than affecting growth factors 
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(Joensuu et al., 1994). Interestingly, although BCL-2 is overexpressed in some cancers, in 
neurodegenerative diseases such as Alzheimer’s and Parkinson’s it may be under expressed, 
leaving the cells more vulnerable to apoptosis (Bar-Am et al., 2005). Studies on the i-motif 
were previously limited, based on the assumption that, because they are stabilized in slightly 
acidic conditions, they were not physiologically relevant, despite a solid foundation of data 
indicating that these structures are detectable at neutral pH in vitro (Mergny et al., 1995). 
In a recent study, Dzatko et al. provided the evidence for i-motif formation in vivo by in cell 
NMR experiments (Dzatko et al., 2018). Moreover, Zeraati et al. reported the generation and 
characterization of an antibody fragment (iMab) that recognizes i-motif structures with high 
selectivity and affinity, enabling to detect i-motifs in cells nuclei (Zeraati et al., 2018). This 
study also showed that the in vivo formation of such structures is also cell-cycle dependent. 
Thanks to iMab, it was demonstrated that i-motif structures are actually formed in regulatory 
regions of the human genome, including promoters and telomeric regions. These results support 
the notion that, as the G4s, i-motif structures could have some key regulatory role in the 
genome.  
 
1.5 DNA sequences as therapeutic agents 
Nucleic acids can be seen not only as a therapeutic target, but also as a new class of potential 
drugs. Among these are the so-called DNA and RNA aptamers. The term ‘aptamer’ derives 
from the combination of the Latin word aptus (‘to fit’) and the Greek word meros (‘part’).  
Nucleic acid aptamers are short, single-stranded DNA (ssDNA) or RNA molecules that are 
selected for binding to a specific target (Morita et al., 2018). The first aptamer was isolated in 
1990, thereafter thousands of aptamers have been generated against a wide range of target, 
including small metal ions, organic molecules, peptides, proteins, viruses, bacteria, whole cells 
and even targets within live animals.  
Aptamers can fold into various non canonical nucleic acid structures (for example stem, 
loop, bulge, G4 and hairpin) (Mayer, 2009), and the peculiar three-dimensional structures allow 
them to specifically recognize their cognate target. The aptamer-target binding leads to a 
complex which is similar to an antibody-antigen complex. However, aptamers offer several 
advantages over traditional antibodies, including smaller size, quick and cheap production, 
versatile chemical modification, high stability, and low immunogenicity. 
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To date, Pegaptanib (®Macugen) is the only commercially available aptamer (Figure 1.18). 
It is a chemically-modified RNA molecule that binds to the isoform 165 of the anti-vascular 
endothelial growth factor (VEGF), a protein that plays a critical role in angiogenesis (the 
formation of new blood vessels) and increased permeability (leakage from blood vessels), two 
of the primary pathological processes responsible for the vision loss associated with 
neovascular age-related macular degeneration (AMD). Pegaptanib works as VEGF antagonist, 
hence reducing the growth of the blood vessels located within the eye and works to control the 
leakage and swelling. 
 
Figure 1.18. Chemical structure of Pegaptanib. 
 
The thrombin binding aptamer (TBA) is further example. It is a 15-mer DNA 
d(GGTTGGTGTGGTTGG) able to fold into an antiparallel G4 (Bock et al., 1992; Nagatoishi 
et al., 2007). It binds to the exosite I of human alpha-thrombin, i. e. binding site of fibrinogen, 
and acts as an anti-coagulant agent by inhibiting the activation of fibrinogen as well as platelet 
aggregation. In addition, TBA shows good affinity and specificity against thrombin. TBA does 
not interact with other plasma proteins or thrombin analogues (e.g., gamma-thrombin) (Li et 
al., 2002) (Figure 1.19). As a result, TBA has been used as a short-term anti-coagulant in the 
coronary artery bypass graft surgery. Its optimized form (NU172) is now under the phase II of 
clinical trial by ARCA Biopharma (NCT00808964). In addition, due to its high affinity and 
specificity, a variety of sensors was coupled with TBA, and developed for thrombosis 
diagnostics.  
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Figure 1.19. Schematic illustration showing (A) the G4 structure of the thrombin binding aptamer (TBA) 
and (B) its interaction with the thrombin exosite I according to the X-ray and NMR studies. Thrombin 
molecule is represented as cartoon, TBA molecule is represented as sticks [adapted from (Krauss et al., 
2012)]. 
 
One of the several therapeutic applications of aptamers is in oncological treatments, where 
they are used for their selective affinity against proteins that play fundamental roles in cancer 
cells. 
AS1411, formerly named ARGO100, is a 26-nucleotide G4-forming oligonucleotide and it 
is the first aptamer in clinical trials for the treatment of human cancer (Soundararajan et al., 
2009). It was originally selected from a screen of antisense oligonucleotides with 
antiproliferative function, then pegylated to prolong its half-life for in vivo applications. Owing 
to its G4 structure, AS1411 is quite resistant to nuclease degradation. AS1411 shows high 
affinity to the external domain of nucleolin (Bates et al., 1999; Soundararajan et al., 2008), 
which is a BCL2-mRNA-binding protein involved in cell survival, growth and proliferation, 
and it is overexpressed on the surface of tumor cells (Berger et al., 2015). After binding to 
nucleolin, and also thanks to macropinocytosis, AS1411 is rapidly internalized, thus leading to 
the induction of apoptosis. AS1411 can function as a tumor-targeting agent and it is a promising 
anticancer agent. It inhibited cancer in various preclinical models (Reyes-Reyes et al., 2010), 
including breast, renal and lung cancer, and in 2007 it was reported to be well tolerated without 
serious side effects in an open-label phase I study on advanced solid tumors (Bates et al., 2009) 
(ClinicalTrials.gov identifier NCT00881244). In 2009, a phase II trial assessed the efficacy and 
safety of AS1411 combined with cytarabine. 
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Chapter 2 
METHODS 
2.1 Circular dichroism 
Circular dichroism (CD) spectroscopy is a of light absorption technique that measures the 
difference in absorbance between the right- and left-circularly polarized light, rather than the 
isotropic light absorption. It is widely used to study the conformations of biomacromolecules 
being very sensitive to their secondary structure, and also thanks to its other advantages, like: 
o Very low sample amount required; 
o Very sensitive detection of conformational changes due to temperature, pH and solvent 
variations. 
The electromagnetic radiation is a complex wave that propagates at the speed of light. It is 
made by two waves that are at right angles to each other and perpendicular to the direction of 
wave propagation: the magnetic (B) and the electric (E) component. Because the two 
components are invariably perpendicular to each other, it is an optimal approximation to 
consider only one of them to simplify the wave description i.e. the E-component. The wave can 
oscillate in any direction perpendicular to the direction of propagation. When the wave passes 
through a polarizer, it is polarized. Linear polarized light occurs when the electric field vector 
(E) propagates in only one plane perpendicular to the direction of propagation, the direction of 
the vector stays constant and the magnitude oscillates (Figure 2.1A). In circularly polarized 
light, the E rotates around the propagation axis maintaining a constant magnitude (Figure 2.1B). 
Light can be circularly polarized in two directions: left and right. If the vector rotates 
counterclockwise when the observer looks down the axis of propagation, the light is left 
circularly polarized. If it rotates clockwise, it is right circularly polarized. The differential 
absorption of radiation polarized in two directions as function of frequency is called dichroism. 
For plane-polarized light this is called linear dichroism, while for circularly polarized light it is 
called circular dichroism.  
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Figure 2.1. A) linearly polarized light; B) circularly polarized light. 
 
Inherently asymmetric chromophores (uncommon) or symmetric chromophores in 
asymmetric environments interact with right- and left-circularly polarized light differently, 
resulting in two related phenomena. Circularly-polarized light will travel through an optically 
active medium with different velocities due to the different indices of refraction for right- and 
left-circularly polarized light. This is called optical rotation or circular birefringence. Right- 
and left-circularly polarized light will also be absorbed to different extents at some wavelengths 
due to differences in extinction coefficients for the two polarized rays called circular dichroism 
(CD):  
CD = AL − AR 
 in which AL is the absorbance of the left-polarized light, and AR is the absorbance of the 
right-polarized one. 
The absorbance is obtained by the Lambert-Beer law: 
A = ε l c 
in which ε is the wavelength-dependent molar absorptivity coefficient (M-1 cm-1), l is the 
optical path length (cm) and c is the sample concentration (M). 
During a CD measurement l and c are constant, hence the CD signal can be expressed as 
difference between molar absorptivity coefficients: 
CD = εL - εR 
An optically active sample, i.e. having different extinction coefficient toward right- and left-
polarized light, introduces difference between the magnitude of the two components. The 
resultant E-vector no longer traces a circle over time but rather an ellipse, thus the light is 
elliptically polarized. Ellipticity is the unit of circular dichroism and is defined as the tangent 
of the ratio of the minor to major elliptical axis. The ellipticity is directly proportional to the 
difference between molar absorptivity coefficients of the two light components: 
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𝜃 =  
𝜋𝜆(𝜀ோ −  𝜀௅)
𝑙
 
in which l is the optical path and λ is the wavelength of the incident radiation.  
A CD spectrum is a measure of the ellipticity vs the wavelength. The spectrum can be 
expressed in molar ellipticity ([θ]) in order to compare spectra achieved at different 
concentrations: 
[θ] = 
ఏ
[௖]·௟
 = 32.98 Δε degrees M-1 cm-1 
A CD spectrum is recorded in the UV-Vis wavelength region. It is similar to the absorption 
spectrum, but it can have positive and negative bands being a difference between molar 
absorptivity coefficients. 
The chromophores that are active to CD are intrinsically dissymmetric molecules. The 
dissymmetry can be structural or a consequence of the presence of a chiral center. CD can be 
applied only to samples that absorb in the UV-Vis region. Buffer baseline is subtracted from 
the CD spectrum of each sample.  
 
2.2 Fluorescence Spectroscopy 
Fluorescence spectroscopy is a technique used to analyze fluorescence emission of a sample. 
It is based on the use of UV or Vis radiation that excites the electrons of molecules in the sample 
and causes them to emit an electromagnetic radiation.  
The fluorescence spectroscopy is: 
o Rapid; 
o Non-destructive technique; 
o Relatively inexpensive; 
o Sensitive: limits of sensitivity depend on intrinsic fluorescent of the sample; however 
this technique is usually able to detect very small concentrations of analytes (μM) and 
has a sensitivity higher than absorption spectroscopy; 
o Specific: the number of fluorescent molecules is limited; 
o Useful to study different types of molecules. 
Moreover, the emission of fluorescence radiation is approximately linear in a wide range of 
concentrations without necessity of sample dilution. 
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Molecules have many accessible electronic states. The electron transition from the ground 
state to an excited state may be induced by electromagnetic radiation. The relaxation to the 
ground state can be spontaneous, because the molecule average lifetime in an excited state is 
limited. In this case the phenomenon is called spontaneous emission. Emission can also be 
induced by the interaction with an electromagnetic radiation and it is called stimulated emission. 
Fluorescence is a spontaneous emission of electromagnetic radiation.  
The phenomenon of spontaneous emission can be explained using the Jablonski diagram 
(Figure 2.2): 
 
 
Figure 2.2. Jablonski diagram. 
 
After molecule absorption of an UV-Vis radiation, the most probable transition occurs with 
conservation of spin multiplicity, i.e. it is the transition from the singlet ground state (S0) to the 
first singlet excited state (S1).  
The molecule in the excited electronic state may be in any vibrational level and it has the 
tendency to return to the ground state. The first phenomenon is the transition from an excited 
to the ground vibrational level. It is called vibrational relaxation and involves the dissipation of 
energy from the molecule to its surroundings. The fluorescence is the emission of 
electromagnetic radiation due to the electron transition from S1 to S0. The intersystem crossing 
is the electron transition from S1 to the triplet excited electronic state (T1). The phosphorescence 
is the emission of radiation due to the electron transition from T1 to S0. When the molecule 
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returns to S0, it may be in any vibrational level and so successively a vibrational relaxation 
occurs. 
Emission bands of a molecule have greater wavelengths compared to those of its excitation 
bands, it is a consequence of energy loss due to non-radiative phenomena. As a result, the 
fluorescence spectrum is similar to the absorption spectrum, but it is shifted to higher 
wavelengths and this shift is called Stokes shift.  
A relevant aspect of the fluorescence is the impossibility to recover the total energy given to 
the molecule with the excitation. The fluorescence quantum yield (φF) provides an estimation 
of the energy recovered through the fluorescence process. It is defined as the ratio of the number 
of photons emitted to the number of photons absorbed. Possible φF values are between zero and 
one: the ratio is near to one if the molecule has a high fluorescence, φF is near to zero if the 
molecule has a low fluorescence. The fluorescent molecule is called fluorophore. 
 
2.3 Electrophoresis 
Electrophoresis is a general term that describes the migration and separation of charged 
particles under the influence of an electric field. Most of biological molecules (e.g. amino acids, 
peptides, proteins, nucleotides, and nucleic acids) has ionizable groups and therefore they can 
be present in solution as charged species in dependence of the pH. 
Gel electrophoresis (GE) is a widely used technique to separate, purify, and identify ionic or 
ionizable macromolecules in solution. An electrophoretic system consists of two electrodes, i.e. 
anode and cathode, connected by a conducting medium called electrolyte, in which the 
electrophoresis gel is immersed. Sample is loaded in appropriate wells and species migrate 
towards either electrode according to their charge.  
The electric force (Fe) is given by the equation: 
Fe = E q 
in which E is the electric field and q the charge. 
There is a friction that opposes to the motion generated by the electric field. The friction 
force is given by: 
Ff = γ v 
in which γ is the friction coefficient and v the migration velocity. 
At constant speed: 
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Fe = Ff 
from which is drawn that: 
v = 
ா ௤
ఊ
 
The electrophoretic mobility (m) is defined as: 
m = 
௩
ா
 = 
௤
ఊ
 
It is noted that the electrophoretic mobility exclusively depends on the particle.  
In the case of a globular molecule, γ is given by: 
γ = 6 π η r 
in which η is the medium viscosity and r the molecule radius. 
Then m is: 
m = 
௤
଺ గ ఎ ௥
 
In conclusion, the electrophoretic mobility of a molecule is determined by its charge, 
dimension and shape, as well as by the medium viscosity and gel pore size. The electrophoresis 
allows the separation of molecules from a mixture according to their charge and size.  
 
2.4 Differential scanning calorimetry 
Differential scanning calorimetry (DSC) is a calorimetric technique used to study 
conformational transitions of biomacromolecules and their thermal stability (Gill et al., 2010). 
DSC major advantages are: 
o Universal technique for its possible application in different research areas; 
o Direct method to determine thermodynamic parameters; 
o The absence of optical constituents allows using cloudy/colored solutions. 
DSC is the main technique for measuring the thermal properties of biomacromolecules, and 
particularly to monitor stability and conformational transitions. It measures the heat capacity 
(Cp) of a sample as a function of temperature, in comparison to a reference.  
In a basic DSC experiment, the sample cell (Figure 2.3) contains a solution with the molecule 
of interest, while the reference cell contains only the solvent. Temperature is raised identically 
in the two cells at constant rate. The difference in energy required to match the temperature of 
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the two cells is the heat either absorbed or released by molecules in the sample during a 
transition. These differences in input energy is a measure of molecule heat capacity. 
 
 
Figure 2.3. Schematic representation of a DSC cells. 
 
An accurate buffer vs buffer (or solvent vs. solvent) baseline scan is required in this 
technique. A second baseline must be applied to the data to extrapolate pre- and post-transition 
DSC curve. The choice of this baseline is the most critical step in the analysis because it affects 
the value of thermodynamic parameters. Several baseline procedures are implemented in DSC 
software, but the simplest approach is a linear extrapolation.  
After a scan sample vs. buffer, the result is a curve (Figure 2.4).  
It is possible to program several consecutive heating/cooling cycles to check for reversibility. 
If the subsequent DSC scans of the same sample overlap, this means that the observed 
unfolding/folding process is fast compared to the scan rate employed in the experiment and can 
be considered, at each temperature, an equilibrium process; suggesting the full reversibility of 
the transition.  
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Figure 2.4. Buffer baseline scan, sample scan (on the left) and final DSC profile (on the right) after 
subtraction of the buffer baseline are shown. Tm is the melting temperature corresponding to the maximum 
of the curve, ΔHo(Tm) is the unfolding enthalpy corresponding to the area under the curve and CPF and CPU 
are the heat capacities of folded (F) and unfolded (U) structures corresponding to the pre- and post-
transition lines, respectively. 
 
Thermodynamic parameters obtained from DSC experiments are quite sensitive to the 
structural state of biomolecules and associate with heat-induced macromolecular transitions.  
The initial part of the curve provides the heat capacity (CpF) of the folded state; while, the 
final part provides the heat capacity (CpU) of the unfolded state instead; their difference 
represents the ΔCp of the molecules transition. The peak is centered at the transition melting 
temperature (Tm). The melting temperature is considered as the temperature at which 50% of 
molecules owns its folded conformation and the rest remains unfolded. Higher Tm values are 
representative of a more stable molecule.  
Calorimetric enthalpy (ΔHocal) is the total integrated zone below the peak, which indicates 
the total transition energy after suitable baseline correction: 
ΔHocal (Tm) = ∫ 𝐶௣௢
்೑
்೔
𝑑𝑇 
in which Ti and Tf are the initial and the final temperature, respectively. 
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Van’t Hoff enthalpy (ΔHoVH) is an independent measurement of the transition enthalpy 
obtained assuming a two-state transition. ΔHoVH is determined through parameters derived from 
the experimental graph: 
ΔHoVH = kRT2ΔCp(Tm)/ΔHocal(Tm) 
in which k is a constant derived from transition stoichiometry, in detail it values 6 for nucleic 
acids and 4 for proteins.  
Information on the transition can be obtained comparing ΔHoVH with ΔHocal. If ΔHoVH is 
equal to ΔHocal, the transition occurs in a two-state mode. When ΔHoVH exceeds ΔHocal, the 
macromolecule may be associated as dimer or multimer. When ΔHoVH is less than ΔHocal, one 
or more intermediates are expected. 
The other thermodynamic parameters are derived from these calorimetric ones. The change 
in entropy (ΔSo) is obtained by: 
ΔSo(Tm) = ∫
஼೛
೚
்
்೑
்೔
𝑑𝑇 
ΔGo must be calculated at a chosen reference temperature: 
ΔGo(T) = ΔHo(T) – TΔSo(T) 
2.5 Nuclear Magnetic Resonance 
Nuclear magnetic resonance (NMR) is a spectroscopic method based on the interaction 
between energy and matter but, differently from other spectroscopic techniques, it needs a 
strong static magnetic field. 
The usefulness of NMR in chemistry was not appreciated until 1950 when the importance 
of the so-called chemical shift was discovered (Proctor and Yu, 1950). Indeed, it is in chemistry 
that NMR has attracted the greatest interest in the recent years. 
Nuclear Magnetic Resonance is a property of the nucleus of an atom, which consists of 
protons and neutrons, related to what is known as nuclear spin (I). This is equivalent to the 
nucleus acting like a miniature bar magnet. The spin of a nucleus depends on the mass of the 
isotope and nuclei with even mass and even charge numbers have no spin angular momentum 
(I=0). These kinds of nuclei are called “NMR inactive” or “NMR silent” since the nuclear spin 
property is fundamental to enable NMR. Nuclei as hydrogen (1H), carbon (13C), fluorine (19F) 
and phosphorus (31P), have I = ½, thus they can be analysed using NMR. 
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As showed in Figure 2.5, when the nuclei are not affected by external magnetic field (B0), 
the spins are randomly oriented in all direction, while if nuclei with I z 0 are placed in a 
magnetic field, they will assume a possible number of different orientations that will correspond 
to specific energy levels; this number depends on the value of I, in particular it is equal to 2I+1.  
 
 
Figure 2.5. a) Randomly oriented spins in the absence of a magnetic field. b) Aligned spins in the presence 
of an applied magnetic field (B0) 
 
The proton (1H) is the most abundant NMR nucleus and it has I = ½, therefore when B0 is 
applied, these nuclei can assume two possible orientations, α parallel (I = ½) or β antiparallel 
(I = - ½), each corresponding to an energy level.  
The difference in the energy levels is equal to: 
∆𝐸 = 𝛾 · 𝐵଴ 
where 𝛾 is the gyromagnetic ratio that is constant for a given nucleus (γ = 2.6752 · 108/T/s 
for protons). 
This means that, given a nucleus, the stronger the magnetic field the higher the gap in the 
energy levels, thus resulting in higher sensitivity in the NMR experiment. 
The protons are distributed between the two energy states according to the Boltzmann 
distribution: 
𝑁ఈ
𝑁ఉ
= exp ൬
∆𝐸
𝑘 ∙ 𝑇
൰ 
Here 𝑁ఈ and 𝑁ఉ represent the protons populations in the lower and upper energy levels, 
respectively, k is the Boltzmann constant and T is the temperature. 
The number of nuclei is not equal in the two states: a small excess of protons will occupy 
the lower energy state (α) since it is, indeed, the more favorable state from an energetic point 
of view. This gives rise to a net magnetization M0, aligned with the applied magnetic field B0. 
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As showed in Figure 2.6, when a radio frequency pulse is applied, the nuclei will absorb 
energy and undergo nuclear spin transitions from lower to higher energy levels, according to 
the following equation: 
∆𝐸 = ℎ · 𝑣 
where h is the Planck constant and v is the frequency of the excitation pulse that induces the 
transition between the levels. This frequency is referred to as Larmor frequency and depends 
both on the nucleus and the magnetic field as showed in the following equation: 
𝑣 =  
𝛾 ∙  𝐵଴
2 ∙  𝜋
 
No NMR signal is observable when the sample is at equilibrium (in the static magnetic field), 
since the net magnetization vector has no component on the xy plane where the signal is 
detected by the detector coil. The duration of the pulse is usually measured in microseconds 
(μs), and it is called 90° pulse when it brings the magnetization on the xy plane, whereas a 180° 
pulse flips the net magnetization on the negative z-axis.  
As illustrated in Figure 2.6, when the radiofrequency is switched off, the system will return 
to equilibrium. This return to equilibrium is referred to as relaxation and it causes the NMR 
signal to decay with time, producing the observed free induction decay (FID). The NMR signal 
is then Fourier transformed to be converted in the frequency domain.  
 
 
Figure 2.6. Schematization of the NMR experiment. 
 
Protons are situated in different positions in a molecule, thus they do not experience the same 
magnetic field for a phenomenon known as shielding. Indeed, the nucleus is surrounded by 
electrons that start a rotational motion when an external magnetic field (B0) is applied. This 
gives rise to a small local magnetic field (Bloc) that may oppose the external field, and, as a 
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consequence, the nucleus experiences a slightly reduced field, that can be called (Beff). A 
specific parameter (σ, shielding constant) is used to indicate the density and the distribution of 
the electronic cloud that surrounds the nucleus. This dimensionless constant ranges from 10-6, 
for lighter nuclei, to 10-3 for heavier ones. The changes in the σ value are given, for example, 
by the presence of functional groups in the vicinity of a nucleus. In particular, when an 
electronegative atom is present, it will withdraw electrons from the observed nucleus, reducing 
the density of the electronic cloud, thus causing a de-shielding effect. Thus, the nucleus will 
resonate at higher frequencies. Considering that Bloc is equal to B0 σ (Lenz rule), Beff is given 
by: 
𝐵௘௙௙ =  𝐵଴ − 𝐵௟௢௖ = 𝐵଴ − 𝐵଴𝜎 = 𝐵଴(1 − 𝜎) 
As a consequence, the relationship between the degree of shielding and the resulting 
resonance frequency is: 
𝑣 =  
𝛾 ∙  𝐵଴
2 ∙  𝜋
 ∗  (1 − 𝜎) 
Therefore, protons situated in different chemical environments will experience different 
magnetic fields, thus meaning that they will resonate at different frequencies giving rise to the 
so-called chemical shift (δ). All the information retrievable from a NMR experiment is hidden 
in the chemical shift, thus it is crucial to only look at the frequencies of the different nuclei in 
a way that is independent from the magnetic field employed. For this reason, a conventional 
way to calculate δ has been established: 
𝛿 =  
𝑣 ∙  𝑣௥௘௙
𝑣௥௘௙
∗ 10଺ 
where v is the frequency of the observed nucleus and vref is the frequency of a reference 
compound. The most widely used reference compounds are tetramethylsilane, Si(CH3)4 (simply 
called TMS) for organic solvents and the sodium salt of trimethylsilyl propionic acid (TSP) for 
aqueous solutions. Both compounds have maximum shielding, showing higher σ than the nuclei 
usually analyzed via NMR. Therefore, the previous equation converts the chemical shift 
frequencies into parts per million (ppm), allowing to display the NMR signals on a new axis on 
which a given spin always shows the same value independently of the magnetic field employed. 
In this new system the reference compound has δ = 0, while the sample resonances have positive 
δ values. 
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Figure 2.7. Approximate proton chemical shifts.  
 
Chemical shift is not the only value to inspect to retrieve chemical information from the 
NMR experiment. Other valuable features are the J coupling and the scalar coupling. This 
phenomenon is due to the fact that the magnetic moments of the nuclei can influence each other 
in two possible ways: through space (dipolar coupling) or through chemical bonds (scalar 
coupling). The effect of the dipolar coupling can be neglected since the interactions average to 
zero because of the rapid molecular tumbling while the scalar coupling is visible from the NMR 
spectrum. 
Indeed, when an atom is influenced by another, this results in the split of its resonance signal. 
When the perturbing nucleus is the observed one, it also exhibits signal splitting. In order to 
observe the splitting of the signal, the interacting nuclei must be bonded in proximity (e.g. 
vicinal and geminal positions) or be oriented in certain optimal configurations. Usually the 
signal splitting in proton spectra ranges from fractions of Hz to around 18 Hz. 
After the nuclei excitation by means of a radiofrequency pulse, the net magnetization will 
flip on the xy plane (90° pulse). Here the spins start to precess (rotate) both clockwise and 
counter-clockwise, thus, a detection system with two simultaneous channels (reciprocally 90° 
out of phase), on each axis, is often employed in order to distinguish the spin with a frequency 
–v and one with a frequency +v. This is called quadrature detection. 
Therefore, after the pulsed excitation, the nuclei return to the equilibrium distribution 
between the two energy levels through a process called relaxation, with relaxation times that 
are specific for different nuclei. This process generates the free induction decay (FID). The FID 
is a time-domain representation of the superimposition of the frequencies of all the nuclei 
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present in the analyzed sample, thus it is not easy to interpret. Fourier transform is a 
mathematical operation that can be carried out on the final FID data to produce the familiar 
frequency spectrum (Figure 2.8). 
 
 
Figure 2.8. Illustration of the Fourier Transformation from the Time Domain s(t) to the Frequency Domain 
S(ω). 
 
2.6 Microscale Thermophoresis 
MicroScale Thermophoresis (MST) is a powerful technique to quantify biomolecular 
interactions. It is based on thermophoresis, the directed movement of molecules in a 
temperature gradient, which strongly depends on a variety of molecular properties such as size, 
charge, hydration shell or conformation. Thus, this technique is highly sensitive to virtually any 
change in molecular properties, allowing for a precise quantification of molecular events 
independent of the size or nature of the investigated compound. During an MST experiment, a 
temperature gradient is induced by an infrared laser. The directed movement of molecules 
through the temperature gradient is detected and quantified using either covalently attached or 
intrinsic fluorophores. By combining the precision of fluorescence detection with the variability 
and sensitivity of thermophoresis, MST provides a flexible, robust and fast way to dissect 
molecular interactions. 
The phenomenon of thermophoresis was first described by Ludwig and describes the 
directed motion of molecules through a temperature gradient. In recent years, MST emerged as 
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a revolutionary method to monitor the directed movement of fluorescent molecules through 
microscopic temperature gradients in µl-volumes, allowing for the precise analysis of binding 
events in a few microliter solution of virtually any molecule–independent of size or physical 
properties (Jerabek-Willemsen et al., 2011; Wienken et al., 2010). Therefore, MST can even 
detect events such as binding of small molecules to proteins, substrates to enzymes, or ligands 
to liposomes. 
Thermophoresis describes a directed movement of particles in a temperature gradient. A 
temperature difference ∆T in space leads to a depletion of the solvated biomolecules in the 
region of elevated temperature, quantified by the Soret coefficient ST:  
𝐶௛௢௧
𝐶௖௢௟ௗ
= exp(−𝑆்∆𝑇) 
This thermophoretic depletion depends on the interface between molecule and solvent. 
Under constant buffer conditions, thermophoresis probes the size, charge and solvation entropy 
of the molecules. Typically, the thermophoresis of a protein significantly differs from the 
thermophoresis of a protein–ligand complex due to binding-induced changes in size, charge 
and solvation energy. Even if ligand binding could not significantly affect the size or charge of 
a protein, MST can still detect it, because of binding-induced changes in the molecules solvation 
entropy (Seidel et al., 2013).  
Figures 2.9 A and B show the Monolith NT.115 instrument from NanoTemper Technologies 
GmbH, the capillary tray that can accommodate up to 16 capillaries, and the schematic 
representation of MST optics. MST is measured in capillaries with a total volume of ∼4 μL. 
The fluorescence within the capillary is excited and detected through the same objective. A 
focused IR-Laser is used to locally heat a defined sample volume. Thermophoresis of 
fluorescent molecules through the temperature gradient is detected and it allows to get the signal 
of an MST experiment (Figure 2.9 C). Initially, the molecules are homogeneously distributed 
and a constant “initial fluorescence” is detected. Within the first second after activation of the 
IR laser, the “T-Jump” is observed, which corresponds to a rapid change in fluorophore 
properties due to the fast temperature change. Subsequently, thermophoretic movement of the 
fluorescently-labeled molecules out of the heated sample volume can be detected. Typically, 
the fluorescence change is measured for 30 s. After deactivation of the IR-Laser, an inverse T-
Jump occurs, followed by the “back-diffusion” of molecules, which is solely driven by mass 
diffusion. 
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Figure 2.9. MST setup and experiments [adapted from (Jerabek-Willemsen et al., 2014)] 
 
In Figure 2.9 D is represented a typical binding experiment in which the thermophoretic 
movement of a fluorescent molecule (black trace; “unbound”) changes upon binding to a non-
fluorescent ligand (red trace; “bound”), resulting in different traces. For analysis, the change in 
thermophoresis is expressed as the change in the normalized fluorescence (ΔFnorm), which is 
defined as Fhot/Fcold (F-values correspond to average fluorescence values between defined areas 
marked by the red and blue cursors, respectively). Titration of the non-fluorescent ligand results 
in a gradual change in thermophoresis, which is plotted as ΔFnorm to yield a binding curve, 
which can be fitted to derive binding constants. 
In recent years, MST was successfully employed to analyze a large variety of bio-molecular 
interactions, ranging from oligonucleotide interactions (Baaske et al., 2010; Seidel et al., 2012), 
protein–DNA interactions (Strauß et al., 2012; Zillner et al., 2013) and protein–protein 
interactions (Arbel et al., 2012; Keren-Kaplan et al., 2013; Lin et al., 2012; Wilson et al., 2012; 
Xiong et al., 2013) to protein–small molecule (Gaffarogullari et al., 2013; Patnaik et al., 2012; 
Seidel et al., 2012; Wienken et al., 2010) and protein–liposome interactions (Van Bogaart et 
al., 2012; Van Den Bogaart et al., 2011). Besides the well-established capability of MST to 
accurately monitor molecular interactions and to derive dissociation constants, thermophoresis 
can also be used to obtain a number of other thermodynamic parameters (ΔH, ΔS, and ΔG), 
allowing the complete characterization of the interaction.  
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Chapter 3 
TARGETING G-QUADRUPLEXES 
Molecular recognition is a very important phenomenon in biology and chemistry, and the 
molecular basis of interaction between small molecules and biological macromolecules is the 
subject of numerous investigations aimed at the rational design of compounds with specific 
biological activities.  
During the last years, after the identification of G4 motifs as biologically relevant elements, 
a certain number of studies about ligand/DNA G4 interactions have been reported (Amato et 
al., 2016; Ou et al., 2008). Since the formation of G4 structures by telomeric DNA inhibits the 
activity of telomerase and their ligand-induced stabilization leads to cellular senescence, small 
molecules that bind and stabilize such G4s could potentially be effective chemotherapeutic 
agents (Neidle, 2009), as well as compounds able to recognize oncogene promoter G4s thus 
suppressing their transcription. In this scenario, the identification of new ligands that are 
specific for the G4 structures is a promising approach to develop new anticancer drugs. Despite 
the fact that the G4 structures differ considerably from the double helix, the design of selective 
ligands is challenging (Burge et al., 2006). Nevertheless, a number of G4 binding agents has 
been proposed so far, and some of these have been demonstrated to have effective anticancer 
activity (Müller and Rodriguez, 2014). 
Therefore, in this Chapter, I will present some studies about the discovery of new G4 binders 
endowed with biological activity. 
 
In Paper I, starting from a promising lead, a small series of novel hydrazone-based 
compounds were synthesized and evaluated as G4 binders. The in vitro G4-binding properties 
of the synthesized compounds were investigated employing both human telomeric and 
oncogene promoter G4s with different folding topologies as targets. Such investigation led to 
the identification of potent G4 stabilizers with high selectivity over duplex DNA and preference 
for one G4 topology over others. Among them, selected derivatives have been shown to trap 
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G4 structures in the nucleus of cancer cells. Interestingly, this behavior correlated with efficient 
cytotoxic activity in human osteosarcoma and colon carcinoma cells (Amato et al., 2016). 
 
In Paper II, the possibility of synthesizing through a multicomponent reaction a new a series 
of furo[2,3-d]pyridazin-4(5H)-one (FP) derivatives as selective binders of BCL2 oncogene 
promoter has been exploited. Biophysical studies showed that two derivatives could effectively 
bind to bcl-2 G4 with good selectivity. Moreover, one such ligand was found to appreciably 
inhibit BCL2 gene transcription, with a substantial decrease in protein expression levels, and 
also showed significant cytotoxicity toward the Jurkat human T-lymphoblastoid cell line 
(Amato et al., 2018). 
 
During my PhD, I also contributed to study a library of analogs of a lead-like G4 targeting 
compound (4c), sharing a furobenzoxazine naphthoquinone core and differing for the pendant 
groups on the N-atom of the oxazine ring, with the aim of developing more potent and selective 
ligands (Paper III) (Amato et al., 2019). These molecules have been tested vs. topologically 
different G4s by the G4-CPG (Controlled Pore Glass) assay, an affinity chromatography-based 
method for screening putative G4 ligands. The obtained results showed that all these 
compounds were able to bind several G4 structures, both telomeric and extra-telomeric, thus 
behaving as multi-target ligands, and two of them fully discriminated G4 vs. duplex DNA. 
Biological assays proved that almost all the compounds produced effective DNA damage, 
showing marked antiproliferative effects on tumor cells in the low PM range. Combined 
analysis of the G4-CPG binding assays and biological data led us to focus on a compound (S4-
5), proved to be less cytotoxic than the parent compound 4c on normal cells. An in-depth 
biophysical characterization of the binding of S4-5 to different G4s showed that the selected 
ligand has higher affinity for the G4s and higher ability to discriminate G4 vs. duplex DNA 
than 4c. Molecular docking studies, in agreement with the NMR data, suggested that S4-5 
interacts with the accessible grooves of the target G4 structures, giving clues for its increased 
G4 vs. duplex selectivity. 
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3.1 New Hydrazone derivatives as specific G-quadruplex binders (Paper I)  
3.1.1 Introduction 
Many research groups have attempted to identify bioactive G4-binding compounds and, to 
date, over 1000 ligands have been reported, representing a wide range of chemotypes 
(Monchaud and Teulade-Fichou, 2008; Ohnmacht and Neidle, 2014). Some of these have been 
identified in order to target the grooves of G4 structures, although most have been devised to 
primarily stack on the external G-tetrads of G4s. The structural features that appear to facilitate 
the latter binding mode are: (i) the presence of an extended planar aromatic scaffold that can 
efficiently stack on terminal G-tetrads through π−π stacking, (ii) an electron-deficient aromatic 
core that can enhance stacking interactions on G-tetrads via cation−π interaction, and (iii) the 
presence of cationic side-chains. These positively charged tethered substituents can interact 
with the grooves and loops of a G4 and with the negatively charged phosphate backbone.  
In 2010, the bis-guanylhydrazone derivative of diimidazo[1,2-a:1,2-c]pyrimidine 1a (in 
order to avoid confusion, compounds 1-10 in Paper I here appear as 1a-10a) (Figure 3.1) was 
reported to be a potent stabilizer of several G4 DNAs, whereas no significant interaction with 
duplex DNA was found (Sparapani et al., 2010). Its high affinity and selective G4-stabilizing 
ability led us to consider 1a as a promising lead compound and to design a small series of 
analogues. For this reason, in collaboration with Dr. Rita Morigi and her research group, 
(Department of Pharmacy and Biotechnology, University of Bologna, Italy) the lead compound 
was chemically modified in order to obtain new derivatives to be tested as G4 ligands (Amato 
et al., 2016). Structural modifications of 1a involved in particular the guanyl chains, the 
substituents at positions 2 and 8 and the core chromophore itself (Figure 3.1). 
The guanyl groups have been modified by introducing a more rigid frame (2a) or an aromatic 
system (4a). Together with compound 2a, the monohydrazone 3a was isolated from the reaction 
mixture and has also been investigated. The phenyl rings at positions 2 and 8 have been replaced 
with the bioisostere thiophene to obtain compound 5a. The tricyclic core has been substituted 
with different systems: the pyrroloindole nucleus to obtain compound 6a or a chloroindole 
moiety (7a, 8a), to achieve core simplification, and finally, core expansion was explored by 
introducing the planar bisindole system of indigo, which was functionalized with iminoguanyl 
or hydrazinylpyridyl groups in order to obtain compounds 9a and 10a. 
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Figure 3.1. Compound lead 1a and structural modifications (in order to avoid confusion, compounds 1-10 
in Paper I here appear as 1a-10a). 
 
3.1.2 Results and discussion 
Circular Dichroism studies 
To evaluate the interaction of compounds 1a−10a with G4 structures, several diverse G4- 
forming sequences able to form parallel, antiparallel, and hybrid G4 structures were selected 
for this study. It is known that human telomeric DNA G4s can adopt different topologies 
depending on the selected sequence and experimental conditions (Dai et al., 2008). In this study, 
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two human telomeric DNA sequences, namely Tel23 and Tel26, were used. They are known to 
form the so-called hybrid-1 and hybrid-2 folds, respectively. In addition, because several 
studies suggest the parallel G4 fold (Parkinson et al., 2002) as the prevalent one in the 
overcrowded solution conditions present inside a cell (Xue et al., 2007), we also prepared a 
Tel23 sample at high DNA concentration conditions in order to promote the parallel G4 
conformation (hereafter referred to as Tel23-p). Further, to determine the affinity of the ligands 
toward other G4 structures, the two G4-forming sequences from the nuclease hypersensitive 
region of the KIT promoter (c-kit1 and c-kit2) and one from the MYC promoter (c-myc) were 
also used. The structures adopted by each G4 sample were verified by circular dichroism (CD) 
spectroscopy. Tel23-p, c-kit1, c-kit2, and c-myc displayed a positive band at 264 nm and a 
negative one around 240 nm in the CD spectrum (Figure 3.2). These bands are characteristic of 
parallel-stranded G4 topologies (Karsisiotis et al., 2011; Masiero et al., 2010). On the other 
hand, Tel23 and Tel26 showed very similar CD spectra having a positive band at 289 with a 
shoulder at ca. 268 nm and a weak negative band at around 240 nm (Figure 3.2). These data are 
consistent with the presence of hybrid structures as major conformations. CD experiments were 
also performed to examine the potential of compounds 1a−10a to alter the native folding 
topology of these G4s. Thus, DNA/ligand complexes were obtained by adding ligands (4 mol 
equivalents) to the folded G4 structures. No significant variations of CD signal were observed 
for any of the structures analyzed here (Figure 3.2), suggesting an overall preservation of their 
G4 architectures upon the addition of each ligand. The structure of a duplex DNA (ds12), which 
is formed by a self-complementary 12-nt sequence, was also verified by CD spectroscopy 
because it has been used in subsequent experiments to evaluate the selectivity of the ligands for 
G4 over duplex DNA. In the presence of K+, the CD spectrum of ds12 was characterized by a 
positive band at around 280 nm and a negative one at 250 nm, typical of values observed for 
duplex DNA (Figure 3.2). These bands were not modified upon ligand addition. 
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Figure 3.2. CD spectra of the investigated DNAs in the absence and in presence of 4 mol equivalents of 
compounds 1a-10a. 
 
The stabilizing properties of the compounds were evaluated by CD-melting experiments 
measuring the ligand-induced change in the melting temperature (ΔTm) of G4 and duplex 
structures. CD-melting curves of DNAs in the absence and presence of each ligand were 
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obtained by following the variations of the intensities of CD signals at the wavelength of 264, 
290, and 280 nm for parallel G4s, antiparallel G4s, and duplex, respectively (Table 3.1). 
 
Table 3.1. Ligand-induced thermal stabilization of G4 and duplex DNAs measured by CD melting 
experiments. 
ΔTm (°C)a 
compd c-kit1b c-kit2c c-mycc Tel23-pb Tel23b Tel26b ds12b 
1ad >15.0 >20.0 >20.0 >20.0 -10.0 -4.5 0.1 
2a 1.6 >20.0 >15.0 10.8 -14.0 -8.9 1.3 
3a 2.7 9.5 >20.0 9.1 -2.4 -3.0 -0.8 
4a 0.4 0.0 -0.2 1.3 -1.0 -1.6 0.9 
5a >15.0 >20.0 >20.0 >20.0 -4.9 -6.5 3.5 
6a >15.0 >15.0 >20.0 >20.0 3.0 1.3 NDe 
7a >15.0 >20.0 >20.0 >20.0 6.0 5.8 NDe 
8a >15.0 >15.0 >20.0 >20.0 5.6 5.1 NDe 
9a 0.9 8.2 11.0 7.7 -0.5 0.2 -0.8 
10a 1.5 2.0 1.6 4.0 -2.5 -2.0 -0.7 
aΔTm represents the difference in melting temperature [ΔTm = Tm(DNA+4 ligand equiv) − Tm(DNA)]. The Tm values of 
DNAs alone are c-kit1 = 69.8 ± 0.5°C, c-kit2 = 62.5 ± 0.5 °C, c-myc = 72.9 ± 0.5 °C, Tel23-p = 68.5 ± 0.5 °C, 
Tel23 = 65.2 ± 0.5 °C, Tel26 = 59.5 ± 0.5 °C, ds12 = 71.3 ± 0.5 °C. All experiments were duplicated, and the 
values reported are average of two measurements. b100 mM KCl buffer. c20 mM KCl buffer. dLead compound. 
eThese compounds significantly increase the thermal stability of ds12, however, ΔTm values cannot be accurately 
determined.  
 
For the first CD-melting experiments, a 4:1 ligand/DNA ratio was used so that all possible 
G4 binding sites were available. Results of these experiments are reported in Table 3.1.On the 
basis of these data, ligands have been ranked in the following categories: (i) compounds that 
exhibit poor G4-stabilizing properties toward any G4 (ΔTm < 5 °C) (compounds 4a and 10a), 
(ii) compounds showing medium G4-stabilizing effect (ΔTm = 5−15 °C) (compound 9a), and 
(iii) potent G4 stabilizers (ΔTm > 15 °C) (compounds 2a, 3a, 5a−8a). As with the lead 
compound 1a, most of the compounds investigated here showed high selectivity for G4 over 
duplex DNA. However, compounds 6a, 7a, and 8a, having a different core from compound 1a, 
were the only ligands to significantly increase duplex stability and therefore were not 
considered to be selective. Interestingly, compounds 2a, 3a, and 5a showed some preference 
for parallel G4s over antiparallel ones. In particular, compound 3a stabilized to a large extent 
only the c-myc G4 (ΔTm > 20 °C). Because we were mainly interested in finding G4 ligands 
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specific for one topology or, even better, for one structure, further studies were only performed 
on compounds 2a, 3a, and 5a. Therefore, we carried out CD melting experiments to investigate 
the effect of increasing concentrations of 2a, 3a, and 5a on the stability of both c-kit2 and c-
myc G4s (Figure 3.3). Three different [ligand]/[DNA] ratio were examined (1:1, 2:1, and 4:1). 
In the case of c-kit2, we observed a dose dependent increase of thermal stability for all three 
compounds although with some differences between them. In particular, compounds 2a and 5a 
increased the Tm of the G4 with every addition of ligand, while 3a, which had shown a modest 
increase in c-kit2 stability, did not induce any further increase of Tm beyond the 2:1 
[ligand]/[DNA] ratio. In the case of c-myc, increasing thermal stability of the G4 with 
compound 3a also ceased at a 2:1 ratio but after a considerable increase of Tm. On the other 
hand, concentration dependency was observed for 2a (although slight compared to c-kit2), 
while the high G4-stabilizing effect of 5a on c-myc did not enable us to assess any dose-
dependent effects. Overall, these results indicate that six out of nine synthesized ligands are 
potent G4 stabilizers. The diimidazo[1,2-a:1,2-c]pyrimidine derivatives having a positive 
charge on the side chain(s) in the used experimental conditions (i.e., 2a, 3a, and 5a) showed 
high affinity toward some of the investigated G4 structures. Conversely, compound 4a, whose 
side chain protonation is less favorable at pH 7.0, showed generally poor G4-stabilizing 
properties. In any case, beyond the overall charge of these ligands, their duplex-binding activity 
is negligible. Concerning the compounds with a different core, the positively charged ones (6a, 
7a, and 8a) showed affinity for some of the G4s investigated as well as for duplex DNA. On 
the other hand, compounds 9a and 10a, whose side chain protonation is less likely to occur at 
pH 7.0, showed medium to low G4-stabilizing properties and negligible effects on duplex. In 
summary, these results indicate that the overall charge of compounds is important in DNA 
binding but, at the same time, suggest that the charge is necessary but not sufficient to ensure 
potent and selective interaction with a specific DNA structure. In addition, CD melting data 
suggest that two molecules of 3a could bind and stabilize the G4 target (the addition of more 
than two equivalents of ligand does not lead to a further enhancement of G4 stability), possibly 
interacting in an end-stacking mode at the terminal G-tetrads of the G4, a common binding 
mode exhibited by the majority of effective G4-targeting ligands. It has to be noted that a 
significant destabilizing effect on Tel23 and Tel26 G4s occurs with some ligands. In particular, 
this phenomenon occurs with compounds 1a, 2a, and 5a, namely the bishydrazone derivatives 
of diimidazo[1,2-a:1,2-c]pyrimidine. The mechanism of destabilization of these G4 structures 
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by such derivatives is unclear and would need further study. However, we hypothesize that it 
may involve nonspecific interactions of compounds with the DNA molecule that might favor 
single stranded DNA, resulting in a shift of folded-unfolded equilibrium toward the unfolded 
form during the melting experiment, which, in turn, may result in a decrease of Tm. 
 
 
Figure 3.3. CD melting experiments of c-kit2 (left column) and c-myc (right column) G4s with increasing 
amounts of compounds 2a, 3a, and 5a. 
 
CD has been also used to investigate the ability of the best ligands (2a, 3a, and 5a) to induce 
G4 formation from unfolded single-stranded DNAs by performing CD titration experiments in 
the absence of metal ions. In particular, the sequences c-kit1, c-kit2, Tel23, and c-myc in 50 
mM Tris buffer were investigated. The CD spectra of c-kit1 and c-kit2 sequences in the absence 
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of monovalent metal cations showed a positive band at around 262 nm and a negative one 
around 240 nm that, even if small, are indicative of the presence of a small percentage of a 
parallel G4 structure in solution. Upon addition of ligands to G4s, a dose-dependent increase of 
the CD bands was observed in some case, suggesting the induction of the parallel G4 structure 
formation. In particular, as far as c-kit2 is concerned, compounds 2a and 5a caused a major 
increase of ellipticity compared to 3a (Figure 3.4). Similarly, the addition of 2a and 5a to the 
c-kit1 sequence also caused a dose-dependent increase in CD signals (more intense for 5a), 
whereas the addition of 3a did not affect the CD profile, thus indicating that 3a is unable to 
induce c-kit1 G4 formation. The c-myc G4 DNA sequence exists in a parallel topology, in the 
absence of any added monovalent metal cation, showing a positive band at 263 nm and a 
negative one around 240 nm. The addition of ligands 2a, 3a, and 5a to c-myc G4 did not perturb 
the parallel G4 structure already formed in Tris buffer. On the other hand, the addition of 
compounds 2a, 3a, and 5a to the Tel23 sequence did not lead to any increase in CD ellipticity, 
thus suggesting that none of them is able to induce any telomeric G4 structures. 
 
Figure 3.4 CD titration spectra of c-kit2 with compounds 2a, 3a and 5a in the absence of metal cations (50 
mM Tris buffer). 
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Fluorescence resonance energy transfer (FRET) melting studies 
The FRET methodology was also used to evaluate the investigated compounds and to 
estimate their G4 vs duplex selectivity (Mergny and Maurizot, 2001). The compounds were 
first screened with the derivatized human telomeric G4 sequence F21T and a duplex DNA 
sequence (T-loop) by using various concentrations of ligands. Similarly to the lead 1a, 
compounds 2a, 3a, and 5a−8a showed potent G4 stabilizing capabilities, while compounds 4a, 
9a, and 10a produced no significant change in G4 melting temperature (Figure 3.5). Among the 
effective G4 stabilizers, compounds 6a, 7a, and 8a showed a significant degree of duplex 
stabilizing ability, confirming once again their low selectivity for G4 over duplex DNA. On the 
other hand, FRET results also confirmed that compounds 2a, 3a, and 5a are effective and 
selective stabilizers of the G4 structures. 
However, the results of these FRET melting experiments cannot be directly compared with 
those obtained from CD melting studies because of differences in DNA sequences and in 
experimental conditions. Therefore, to more fully compare the results of CD melting 
experiments obtained for compounds 2a, 3a, and 5a, additional FRET melting experiments 
were performed on these ligands under the same buffer conditions used for CD, using as targets 
the labeled G4-forming oligonucleotides from the KIT (Fckit2T) and MYC (FcmycT) promoter 
regions and the telomeric G4-forming sequence annealed at high concentration to promote the 
parallel conformation (F21T-p) (Figure 3.5). 
The results of FRET melting experiments, shown in Table 3.2, are in good qualitative 
agreement with those obtained from CD melting studies. The FRET ranking order reflects that 
compared to the CD melting data; the fact that the ΔTm values themselves are somewhat 
different is likely to be a consequence of different techniques and does not have particular 
significance. 
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Figure 3.5. Thermal stabilization (ΔTm) of F21T G4 and hairpin ds-DNA (T-loop) induced by the 
investigated ligands (1a-10a) at various concentrations (PM) measured by FRET-melting experiments. 
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Table 3.2. Ligand-induced thermal stabilization of labeled G4-
forming sequences evaluated by FRET melting analyses. 
ΔTm (°C)a 
compd Fc-kit2Tb Fc-mycTb F21T-pc 
2a >20.0 >15.0 >15.0 
3a ≈15.0 >20.0 7.0 
5a >20.0 >20.0 >20.0 
aΔTm represents the difference in melting temperature [ΔTm = Tm (G4+4 ligand 
equiv) − Tm (G4)]. Tm values of G4s alone: Fc-kit2T = 66.3 ± 1.0 °C, Fc-
mycT = 68.6 ± 1.0 °C, F21T-p = 67.1 ± 1.0 °C All experiments were 
duplicated, and the values reported are average of two measurements. b20 
mM KCl buffer. c100 mM KCl buffer. 
 
 
Nuclear Magnetic Resonance studies 
NMR spectroscopy was employed in order to obtain structural information about the binding 
mode of compound 3a. As stated above, this compound is a potent and specific stabilizer of c-
myc G4. Because the wild-type G4 sequence of c-myc is not suitable for study by NMR (its 1H 
NMR spectrum is affected by the presence of minor conformations), the well-characterized 
modified sequence (myc22) containing two G-to-T mutations at position 14 and 23 was used 
for the NMR titration experiments. The spectral regions of the imino and aromatic protons in 
the absence and presence of increasing amounts of compound 3a are shown in Figure 3.6A. 
According to the literature, under the experimental conditions used, the myc22 DNA sequence 
forms a single G4 conformation characterized by 12 well-resolved imino protons peaks, 
corresponding to the 12 guanines involved in the three G-tetrad planes (Ambrus et al., 2005). 
Upon addition of compound 3a to the myc22 solution, both imino and aromatic protons became 
broad even at higher drug equivalence, indicating a dynamic binding process of 3a to myc22 
with a medium exchange rate on the NMR time scale. The titration was virtually complete at a 
ligand/DNA ratio of 2:1. Major chemical shift changes were observed for the imino protons 
belonging the 5’ G-tetrad (G7−G11−G16−G20) as well as for G9 of the 3’ G-tetrad (G9−G13−
G18−G22), while the remaining imino protons of G13, G18, and G22 at the 3’-end tetrad and 
those of middle tetrad (G8−G12−G17−G21) were less affected. The origin of this different 
behavior could be due to inherent structural features associated with the 3’- and 5’-faces as well 
as the flanking sequences. The 5’ side is more accessible for ligand stacking and the only 5’-
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flanking residue particularly affected by the binding turned out to be the T4, as shown by the 
corresponding aromatic proton shift. By contrast, the 3’-face is less accessible. A25 from this 
side folds back to form a base pair with T23 to cover the external G-tetrad, while A24 stays 
above the T23:A25 base pair. However, these latter flanking residues are not able to completely 
prevent the binding. Upon addition of 3a, the aromatic protons of T23, A24, and A25 were 
strongly perturbed, suggesting that the ligand can be positioned between the four guanines of 
the 3’-tetrad and the 3’-flanking bases. The stability of the 3’-end bound ligand complex with 
myc22 could be related to the possibility of specific H-bond interactions between the imidazole 
group of 3a and the 3’-flanking bases (as discussed in the docking section). For comparison, 
we have also examined the binding behavior of 3a to the c-kit2 G4. Because the c-kit2 G4 wild-
type sequence gives poorly resolved imino proton NMR spectra, we used the modified sequence 
c-kit2T12/T21 (in which G12 and G21 are replaced by two T residues), which is known to fold 
into a monomeric parallel G4 structure with well-resolved imino proton signals (Hsu et al., 
2009; Kuryavyi et al., 2010). Figure 3.6B shows the spectral regions of the imino and aromatic 
protons of c-kit2T12/T21 in the absence and presence of increasing amounts of compound 3a. 
Interestingly, the imino signals belonging to the G-tetrad on the 5’-side (G2, G6, G14, and G18) 
were equally affected with respect to those belonging to the 3’-terminal G-tetrad, as well as the 
aromatic protons of C1 and A13 on the 5’-face and those of C9 and T21 on the 3’-face. These 
results clearly suggest an involvement of both external G-tetrads in binding, despite the 
potential pairing between residues C1 and A13 on the 5’-side (Kuryavyi et al., 2010). Thus, we 
hypothesize that 3a is able to interact with both the 5’ and 3’ G-tetrads, possibly by displacing 
the C1 and A13 base pairing at the former. Overall, these findings suggest that compound 3a 
binds to the 5’- and 3’-terminal G-tetrads of both myc22 and c-kit2T12/T21 G4s. However, some 
differences in the binding to the two G4s were observed that could explain the difference in the 
thermal stabilization of the two G4s upon binding observed by CD analysis. Particularly, we 
speculate that this different binding behavior is due to the possibility of 3a forming specific H-
bond interactions with myc22 (see Molecular Docking section), thus ensuring that compound 
3a binds more effectively to the c-myc G4 rather than to the c-kit2 G4. 
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Figure 3.6. Imino and aromatic proton regions of (A) MYC promoter G4 (myc22) in 25 mM phosphate, 70 
mM KCl solution (pH 7.0), and (B) KIT promoter G4 (c-kit2T12/T21) in 5 mM phosphate, 20 mM KCl solution 
(pH 6.8) titrated with compound 3a. 
 
 
Molecular Docking  
Molecular docking calculations were performed to provide a possible molecular basis for 
the G4 binding of 3a. We docked the ligand to the three-dimensional structures of c-kit2 and c-
myc G4s determined by solution state NMR spectroscopy (Dai et al., 2011; Hsu et al., 2009). 
Taking into account the experimentally suggested binding stoichiometry, 2:1 (ligand/DNA) 
complex models were built with the G4 targets. Both 5’- and 3’-terminal G-tetrads were 
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considered as potential binding sites for the ligand and were therefore examined in the docking 
procedures. For each binding site, the most favorable complex was selected from the docked 
structures on the basis of the calculated binding energies. The low-energy binding poses for the 
ligand are shown in Figure 3.7. The shape of 3a effectively fills much of the available space in 
the plane of the two G-tetrads in the c-myc G4. The tricyclicdiimidazo[1,2-a:1,2-c]pyrimidine 
moiety is stacked onto the planes at a 3.4 Å separation at both 5’- and 3’-faces and overlaps 
part of two guanine bases (G11 and G16 at the 5’ G-tetrad; G9 and G13 at the 3’ G-tetrad), 
making extensive π-stacking interactions (Figure 3.7A). In both cases, one of the two attached 
phenyl rings overlap part of a guanine of the tetrad, contributing to the stabilization, while the 
other one is twisted out of the diimidazo[1,2-a:1,2-c]pyrimidine plane. The 2-hydrazino-2-
imidazoline groups of the two ligand molecules make close hydrogen bonds with the oxygen 
atoms of the backbone phosphate groups of the G4. It is noteworthy that the formyl group of 3 
is, in both cases, hydrogen bonded to the first flanking base (A6 and T23 at 5’- and 3’-end, 
respectively) that stacks over the G-tetrad, thus forming a plane capping the 5’ and 3’ external 
G-tetrads of the c-myc G4. In the case of c-kit2 G4, different binding poses were observed for 
the ligand on the two external G-tetrad surfaces (Figure 3.7B). Indeed, the molecular model of 
3a bound to the c-kit2 G4 shows that at the 3’-end, the planar aromatic scaffold of the ligand 
makes π-stacking interactions with the 3’ G-tetrad, while the 2- hydrazino-2-imidazoline group 
is positioned to participate in a hydrogen bond with a phosphate group. However, by contrast 
with the c-myc G4, compound 3a does not form any additional interaction to further stabilize 
the complex. On the other hand, the docking calculations at the 5’-face of the c-kit2 G4 structure 
reveal that to make hydrogen-bonding/electrostatic contacts between the charged 2-hydrazino-
2-imidazoline group and the backbone phosphate groups of the G4, the side chain of compound 
3a needs to be located in the deep groove formed by the long loop 2 of the G4. As a 
consequence, the diimidazo[1,2-a:1,2-c]pyrimidine core of 3a results in not being parallel to 
the plane of the terminal G-tetrad. This is probably due to the 5’ -3’ strand polarity generated 
by the propeller loop topology of this G4, which does not expose the phosphodiester backbone 
on this side, thus making only the 3’-end more favorable to interact with ligands with positively 
charged side chains. Overall, the docking results reveal that 3a has the appropriate shape and 
electronic structure to form specific interactions. Interestingly, the binding of 3a could involve 
the first flanking bases to form a plane covering the external G-tetrads and contributing greatly 
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to the G4 stabilization. This could also explain the selectivity of 3a in increasing the thermal 
stability of the c-myc G4. 
 
 
 
Figure 3.7. Predicted binding poses upon docking of compound 3a onto the (A) c-myc and (B) c-kit2 G4s. 
Ligand molecules are represented as sticks. The phosphate backbone and nucleosides of G4s are 
represented in tube and stick representations, respectively. Black dashed lines indicate hydrogen bond 
interactions. 
 
Biological assays 
Biological assays were performed in collaboration with Prof. Giovanni Capranico 
(Department of Pharmacy and Biotechnology, University of Bologna, Italy). specificity for 
different G4 structures, we next determined the effects of selected compounds at cellular levels. 
We selected compound 3a as it was the most selective agent in vitro, and we compared its 
effects with those of 1a and 14a , used as a negative control because it is unable to bind G4s in 
vitro) (Figure 3.8) (Sparapani et al., 2010).  
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Figure 3.8. Structures of the compounds 1a, 3a, 14a. 
 
First, we determined the cell killing activity of the three selected molecules with the thiazolyl 
blue tetrazolium bromide (MTT) assay in two human cancer cell lines: the Human Bone 
Osteosarcoma Epithelial Cell line (U2OS) and colon cancer HCT116 lines. In this assay, after 
exposure to the compounds, cells were allowed to recovery in drug-free medium for 24−48 h 
before adding MTT to measure surviving cells. 
HCT116 cells were more sensitive than U2OS cells to the tested compounds, however, both 
cell lines were more sensitive to compound 3a than other agents (Table 3.3) 
 
Table 3.3. Cytotoxic activity of selected hydrazone derivatives in human U2OS and HCT116 cellsa. 
IC50 (µM) 1 h IC50 (µM) 24 h 
compd U2OS HCT116 U2OS HCT116 
1ad 101.0 ± 1.63 35.07 ± 1.06 15.97 ± 1.41 5.12 ± 1.05 
3a 5.73 ± 1.48 4.18 ± 1.07 0.845 ± 0.001 0.407 ± 0.106 
14a 45.23 ± 2.05 16.79 ± 1.06 9.16 ± 1.44 4.06 ± 1.07 
aThe concentrations killing 50% of cells (IC50) are means ± SE of two independent experiments performed in 
triplicates. 
 
In particular, compound 3a showed high cell killing activity in U2OS cells after 24 h of 
treatment (IC50 = 0.845 μM). In addition, 3a was 20- and 12-fold more cytotoxic than 
compounds 1a (IC50 = 15.97 μM) and 14a (IC50 = 9.16 μM), respectively. Similarly, 3a was 
more cytotoxic than compounds 1a and 14a after 1 h of cell treatment (Table 3.3).The 
sensitivity pattern was very similar in HCT116 cells, with compound 3a showing highest cell 
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killing activity as compared with compounds 1a and 14a both after 24 and 1 h of treatment 
(Table 3.3). Therefore, the results established that compound 3a is more cytotoxic than the other 
tested compounds, at least in the two cell lines used here. Next, to show whether 3a and 1a 
stabilized G4s in living cells, we visualized nuclear G4 structures in human U2OS cells by 
immunofluorescence microscopy using the BG4 antibody, a known specific antibody against 
G4s (Biffi et al., 2013). U2OS cells were treated for 24 h with compound concentrations very 
close to the established IC50 values (Table 3.3). Immediately after treatments with tested 
compounds, cell death was minimal, as determined by cell fluorescence activated cell sorting 
(FACS) analyses and microscopy visualization. After incubation with BG4 antibody, the 
fluorescence signal was generated by a final incubation with a fluorochrome-labeled antibody 
and measured and analyzed with ImageJ. BG4 showed nuclear staining in control, untreated 
cells indicating that G4 structures were present at discrete chromatin sites in the nucleus (Figure 
3.9A), in agreement with previous studies (Biffi et al., 2013). Fluorescence spots were of 
different sizes, and larger spots apparently consisted of a few smaller spots. The fluorescence 
patterns were similar in cells treated with the three selected hydrazone derivatives. However, 
the compound effects were very different because compounds 3a and 1a, but not 14a, markedly 
increased the number, size, and fluorescence intensity of nuclear spots, thus indicating that they 
could stabilize G4 structures in the nucleus of living cells. We then measured the total 
fluorescence signal per cell for each sample, and the results indicated that 3a was the most 
potent as an increase of G4 signal was detected even at 0.2 μM (a dose 4-fold lower than IC50), 
and further increased at 1 μM, of 3a. Compound 1a was able to increase the nuclear G4 signal 
at 10 μM at comparable levels as 3a at 0.2 μM (Figure 3.9A). In contrast, 14a did not show any 
increase in fluorescence intensity at the tested concentrations significant increase of G4 after 
0.2 μM (p = 2.05 × 10−32) and 1 μM (p = 1.82 × 10−55) of compound 3a and 10 μM (p = 2.44 × 
10−38) of 1a. Taken together, these data demonstrate that hydrazone derivatives can stabilize 
G4s in cultured human cancer cells and that 3a is the most potent agent among the studied 
derivatives. Although we detected an association of cytotoxic potency with G4 stabilization in 
living cells among the tested compounds, further investigations at the cellular level are needed 
to establish a clear link between G4 stabilization and biological activity of these hydrazone 
derivatives. 
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Figure 3.9. (A) Immunofluorescence showing BG4 foci (green) in human osteosarcoma U2OS cell nuclei 
(blue). Cells were treated with G4 ligands for 24 h and then fixed. G4s and DNA were stained with BG4 
antibody and DAPI, respectively. (B) Box Plot analysis of G4 signal in the nucleus of control and treated 
cells. At least two experiments were considered, and 150 nuclei were counted per sample. Statistical 
significance was determined with the t test, and * indicates a p value less than 10−32. 
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3.1.3 Conclusions 
Starting from the lead compound 1a, a series of analogues with structural modifications of 
the substituents and the core have been designed, synthesized, and evaluated as effective and 
selective G4 binding ligands. The results from CD assays showed that six out of nine 
synthesized ligands are potent G4 stabilizers that retain the pre-existing architecture of the 
target G4s upon interaction. However, the compounds having a different core from that of 
compound 1a (6a, 7a and 8a) were also shown to increase the stability of duplex DNA and 
therefore they are not selective for G4s. On the other hand, compounds 2a, 3a, and 5a displayed 
a marked preference for binding parallel G4s over duplex and antiparallel G4s. 
Therefore, it was investigated in detail in terms of binding mode. NMR experiments 
suggested an end-stacking binding mode at the terminal G-tetrads of the G4 with a 2:1 
drug/DNA binding stoichiometry. Molecular docking results provided further insight into the 
recognition between 3a and the G4 DNA, highlighting the possible key structural elements 
involved in the interaction. Interestingly, compound 3a, which is the only monohydrazone of 
the series, appears to have the appropriate structure to stack on the planar G-tetrad surfaces of 
c-myc G4 with the tricyclic diimidazo[1,2-a:1,2-c]pyrimidine core and, at the same time, to 
make (i) close hydrogen-bonding/electrostatic contact between the charged 2-hydrazino-2-
imidazoline group and the oxygen atoms of the backbone phosphate of G4 and (ii) a hydrogen 
bond interaction between the formyl group at position 3 and the hydrogen-bond donor groups 
of the first flanking base that stacks on the G-tetrad. 
In line with the in vitro assays, biological experiments demonstrated that hydrazine 
derivatives can effectively trap G4 structures in the nuclei of cells. Remarkably, derivative 3a 
is more effective than the lead compound 1a in inhibiting human U2OS and HCT116 cancer 
cell growth as well as in stabilizing G4s in osteosarcoma cells. Altogether, the reported results 
indicate that this molecular scaffold could actually form the basis for the development of highly 
selective drug-like G4 ligands with superior biological activity to accomplish the desired result 
of achieving new and effective anticancer drug candidates. 
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3.1.4 Experimental Section 
Oligonucleotide synthesis and sample preparation 
The DNA sequences were synthesized using standard β-cyanoethylphosphoramidite solid 
phase chemistry on an ABI 394 DNA/RNA synthesizer (Applied Biosystem) at the 5 μmol 
scale. DNA detachment from support and deprotection were performed by treatment with 
concentrated ammonia aqueous solution at 55 °C for 12 h. The combined filtrates and washings 
were concentrated under reduced pressure, dissolved in water, and purified by high-
performance liquid chromatography (HPLC) on a Nucleogel SAX column (Macherey- Nagel, 
1000−8/46), using buffer A consisting of 20 mM KH2PO4/ K2HPO4 aqueous solution (pH 7.0), 
containing 20% (v/v) CH3CN, buffer B consisting of 1 M KCl, 20 mM KH2PO4/K2HPO4 
aqueous solution (pH 7.0), containing 20% (v/v) CH3CN, and a linear gradient from 0% to 
100% B for 30 min with a flow rate 1 mL/min. The fractions of the oligomers were collected 
and successively desalted by Sep-pak cartridges (C-18). The isolated oligomer was proved to 
be >98% pure by NMR. In particular, the following oligonucleotides have been synthesized: 
d[TAGGG(TTAGGG)3] (Tel23) and d[(TTAGGG)8TT] (Tel26) that are two different 
truncations of human telomeric sequence, two sequences that occur in the nuclease 
hypersensitive region of the promoter of KIT oncogene 
d(AGGGAGGGCGCTGGGAGGAGGG) (c-kit1) and 
d(CGGGCGGGCGCGAGGGAGGGG) (c-kit2), the modified c-kit2 promoter sequence 
d(CGGGCGGGCGCTAGGGAGGGT) (c-kit2T12/T21), the MYC promoter sequence 
d(TGAGGGTGGGGAGGGTGGGGAAGG) (c-myc), the modified MYC promoter sequence 
d(TGAGGGTGGGTAGGGTGGGTAA) (myc22), and the self-complementary duplex 
forming dodecamer d(CGCGAATTCGCG) (ds12). The concentration of oligonucleotides was 
determined by UV adsorption measurements at 90 °C using appropriate molar extinction 
coefficient values ε (λ = 260 nm) calculated by the nearest neighbor model (Cantor et al., 1970). 
Samples were heated at 90 °C for 5 min and then gradually cooled to room temperature 
overnight. Parallel arrangement of telomeric sequence (Tel23-p) was prepared as previously 
described (Pagano et al., 2015). 
 
Circular dichroism spectroscopy 
Circular dichroism (CD) experiments were recorded on a Jasco J-815 spectropolarimeter 
equipped with a PTC-423S/15 Peltier temperature controller. All the spectra were recorded at 
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20 °C in the wavelength range of 230−360 nm and averaged over three scans. The scan rate was 
set to 100 nm/min, with a 1 s response time and 1 nm bandwidth. Buffer baseline was subtracted 
from each spectrum. For the CD experiments in the presence of metal cations, 10 μM G4 DNA 
and 15 μM duplex DNA were used. CD spectra of DNA/ligand mixtures were obtained by 
adding 4 molar equivalents of ligands (stock solutions of ligands were 6 mM in DMSO). DNAs 
were prepared in 10mM potassium phosphate (for c-kit1, Tel23, and Tel26) or 10mM lithium 
phosphate (for Tel23-p and ds12) buffers (pH 7.0) containing 100 mM KCl. Because the Tm 
value of the c-myc G4 alone is above 80 °C in buffer containing 100 mM KCl, it is very difficult 
to evaluate the stabilizing effects of adding ligands, thus a buffer solution containing lower 
amounts of K+ (5 mM potassium phosphate, 20 mM KCl) was used for the experiments on c-
myc G4. As for c-kit2, it was shown that this sequence forms a dimeric G4 in 100 mM K+-
containing solution (Kuryavyi et al., 2010), with a completely different fold compared to the 
monomeric G4 that is formed in buffer solution containing low amounts of K+ (Hsu et al., 2009; 
Kuryavyi et al., 2010). Therefore, 5 mM potassium phosphate buffer containing 20 mM KCl 
was also used in this case. All spectra were baseline corrected and analyzed using Origin 7.0 
software. For the studies in the absence of metal cations, oligonucleotides (12−15 μM) were 
prepared in 50 mM Tris buffer and the CD spectra were recorded 10 min after each ligand 
addition (stepwise additions of 0.5 mol equivalents). All spectra were baseline corrected and 
analyzed using Origin 7.0 software. CD melting were carried out in the 20−100 °C temperature 
range at 1 °C/min heating rate by following changes of CD signal at the wavelengths of the 
maximum CD intensity. CD melting experiments were recorded in the absence and presence of 
ligands (4 mol equivalents) added to the folded DNA structures. For selected compounds, CD 
melting experiments were also performed by varying ligand concentration. Three different 
[ligand]/[DNA] ratio were examined (1:1, 2:1 and 4:1). The melting temperatures (Tm) were 
determined from curve fit using Origin 7.0 software. ΔTm values were determined as the 
difference in melting temperature between the G4-DNA with and without ligands. 
 
FRET melting studies 
The ability of the compounds to stabilize DNA sequences was investigated using a 
fluorescence resonance energy transfer (FRET) assay modified to be used as a high-throughput 
screen in a 96-well format. The studied sequences were the G4 forming sequence 5’-FAM-
d(GGG[TTAGGG]3)-TAMRA-3’ (F21T) (Mergny and Maurizot, 2001), and the duplex-
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forming sequence 5’-FAM-d(TATAGCTATA-HEG-TATAGCTATA)-TAMRA-3’ (T-loop) 
(HEG linker: [(−CH2−CH2−O−)6]). The labeled oligonucleotides had attached to them the 
donor fluorophore FAM, 6-carboxyfluorescein, and the acceptor fluorophore TAMRA, 6-
carboxytetramethylrhodamine. The FRET probe sequences were diluted from stock to the 
correct concentration (400 nM) in a 60 mM potassium cacodylate buffer (pH 7.4) and then 
annealed by heating to 85 °C for 10 min, followed by cooling to room temperature in the heating 
block. The compounds were stored as a 10 mM stock solution in dimethyl sulfoxide (DMSO); 
final solutions (at 2× concentration) were prepared using 10 mM HCl in the initial 1:10 dilution, 
after which 60 mM potassium cacodylate buffer (pH 7.4) was used in all subsequent steps. The 
maximum HCl concentration in the reaction volume (at a ligand concentration of 20 μM) is 
thus 200 μM, well within the range of the buffer used. Relevant controls were also performed 
to check for interference with the assay. 96-Well plates (MJ Research, Waltham, MA) were 
prepared by aliquoting 50 μL of the annealed DNA into each well, followed by 50 μL of the 
compound solutions. Measurements were made on a DNA Opticon Engine (MJ Research) with 
excitation at 450− 495 nm and detection at 515−545 nm. Fluorescence readings were taken at 
intervals of 0.5 °C in the range 30−100 °C, with a constant temperature being maintained for 
30 s prior to each reading to ensure a stable value. Final analysis of the data was carried out 
using a script written in the program Origin 7.0 (OriginLab Corp., Northampton, MA). The 
advanced curve-fitting function in Origin 7.0 was used for calculation of ΔTm values. All 
determinations were performed in triplicate. Esds in ΔTm are ±0.2 °C. For selected compounds, 
additional FRET melting studies were performed by using the following G4 forming sequences: 
the 5’-FAM-d(GGGCGGGCGCGAGGGAGGGG)-TAMRA-3’ (Fckit2T) and 5’-FAM-
d(TGAGGGTGGGTAGGGTGGGTAA)-TAMRA-3’ (FcmycT) oligonucleotides from the 
KIT and MYC promoter regions, respectively, and the telomeric F21T G4-forming sequence 
were annealed at high concentrations to promote the parallel conformation (F21T-p). Labeled 
oligonucleotides were purchased from Biomers (Germany) and purified employing standard 
HPLC protocols. Such studies were performed under the same buffer and experimental 
conditions used for the corresponding CD experiments. The FRET melting assay was carried 
out on a FP-8300 spectrofluorometer (Jasco) equipped with a Peltier temperature controller 
accessory (Jasco PCT-818) with excitation at 492 nm and detection at 522 nm. Both excitation 
and emission slit widths were set at 5 nm. A sealed quartz cuvette with a path length of 1 cm 
was used. The final concentration of the G4s was 0.2 μM. The fluorescence melting of the G4s 
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was monitored at 1 °C/min with and without ligands (at a 4:1 ligand/DNA ratio). Final analysis 
of the data was carried out using Origin 7.0. 
 
Nuclear Magnetic Resonance 
NMR experiments were performed on a 700 MHz Varian Unity INOVA spectrometer, with 
data recorded at 25 °C. One-dimensional proton spectra of the sample in H2O were recorded 
using pulsed-field gradient DPFGSE for H2O suppression. DNA samples were prepared at 0.2
−0.5 mM strand concentration in 0.6 mL of (H2O/D2O 9:1) buffer solution. NMR experiments 
on G4 forming oligonucleotides from MYC (myc22) and KIT (c-kit2T12/T21) promoters were 
performed by employing the same buffers and experimental conditions as used for the 
determination of their 3D structures (Ambrus et al., 2005; Kuryavyi et al., 2010) in order to 
avoid different G4 folds or conformational heterogeneity in solution, which is detrimental to 
such experiments. The solution was either 25 mM KH2PO4, 70 mM KCl, 0.2 mM EDTA, pH 
7.0 (for Myc22), or 5 mM KH2PO4, 20 mM KCl, 0.2 mM EDTA, pH 6.8 (for c-kit2T12/T21). 
Aliquots of a stock solution of 3a in DMSO-d6 were added directly to the DNA solution inside 
the NMR tube. The NMR data were processed on an iMAC running iNMR software 
(www.inmr.net). 
 
Docking simulations 
The solution structures of G4 formed by the human c-kit2 promoter sequence (PDB ID: 
2KQH) (Hsu et al., 2009) and of c-myc G4 bound to quindoline molecule (PDB ID: 2L7V) (Dai 
et al., 2011) were used as the targets for docking studies. The ligand found in the c-myc complex 
was removed from the structure to leave empty binding sites. After optimizing the ligand and 
assigning partial atomic charges, docking calculations were performed with the AutoDock 4.2 
program using the Lamarckian genetic algorithm (Morris et al., 2009). The all-parallel-stranded 
arrangement with propeller loops linking adjacent parallel strands on opposite surfaces of the 
G4s results in accessible outer planar G-tetrad surfaces that, being the potential binding sites 
for the ligands, were defined as the grid boxes for the docking. The size of the boxes was 
constrained to 18 Å × 18 Å × 18 Å in the x, y, and z dimensions. Grid maps were generated for 
each atom type in the ligand using AutoGrid. An active site box was created with a grid spacing 
of 0.375 Å. The maximum number of energy evaluations was set to 2.5 × 106, the maximum 
number of genetic algorithm operations was set to 2.7 × 104, the number of individuals in a 
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population was set to be 300, and the rates of mutation and crossover were set to 0.02 and 0.8, 
respectively. When searching the conformational and orientation spaces of ligand with rotatable 
bonds having full flexibility, the structure of the G4 was kept rigid. The most favorable binding 
poses were selected on the basis of both the calculated energies and visual inspection. All the 
figures were drawn using VMD 1.9 software (www.ks.uiuc.edu/Research/vmd). 
 
Cell culture and Immunofluorescence 
Human osteosarcoma U2OS and colon cancer HCT116 cells were cultured in Dulbecco’s 
Modified Eagle Medium (DMEM) (Carlo Erba), supplemented with 1% L-glutamine and 10% 
fetal bovine serum (FBS). U2OS cells were seeded in 35 mm dishes at a concentration of 
100000 cell/mL. Twentyfour hours after seeding, cells were treated with 1a (2 and 10 μM), 3a 
(0.2 and 1 μM), or 14a (2 and 10 μM). Cells were then fixed in methanol:acetic acid (3:1), 
permeabilized with 0.1% triton-X100/PBS, and blocking in 2% milk/PBS. 
Immunofluorescence was performed using standard methods with BG4, anti-FLAG (Cell 
Signaling Technology), and antirabbit Alexa 488-conjugated (Invitrogen) antibodies. Nuclei 
were stained with 4’,6-diamidino-2-phenylindole (DAPI) (Sigma-Aldrich), and coverslips were 
mounted with Mowiol 4−88 (Sigma-Aldrich). Fluorescence signal was determined using 
ImageJ software with the following formula: corrected total cell fluorescence (CTCF) = 
integrated density − (area of selected cell × mean fluorescence of background readings). 
Significance was determined by parametric tests “Student’s t test”. BG4 antibody was obtained 
by transfection of BG4 plasmid (kindly obtained by S. Balasubramanian) in BL21 Escherichia 
coli cells. Then BG4 protein expression was induced by the autoinduction method as described 
by Studier (Studier, 2005). BG4 was purified by using silica-based resin (Protino Ni-IDA) 
precharged with Ni2+ ions, eluted with 250 mM Imidazole/PBS pH 8.0. The eluted antibody 
was concentrated with Amicon Ultra-15 centrifugal filter units (Millipore), and imidazole was 
finally removed by buffer exchange with PBS pH 8.0 with Amicon Ultra-15 centrifugal filter 
units. 
 
MTT Cell Proliferation Assay 
U2OS and HCT116 cells were cultured in DMEM as above and were seeded in 24-wells at 
a concentration of 40000 cell/mL. Twenty-four hours after seeding, cells were treated with the 
compound at the indicated concentration and time. After 1 or 24 h of treatment, agents were 
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removed and cells were further cultured in complete drug-free medium for 1−2 days. Then, 
MTT (Sigma-Aldrich) was added to each well and incubated for 1 h at 37 °C. Then medium 
was removed and 300 μL of DMSO (Sigma-Aldrich) were added and incubated for 1 h at room 
temperature. Then 100 μL of the solution was put in 96-well, and absorbance at 595 nm was 
measured using a multiplate reader. The linear regression parameters were determined to 
calculate the IC50 (GraphPad Prism 4.0, Graph Pad Software Inc.). 
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3.2 Targeting the BCL2 Gene Promoter G-Quadruplex with a New Class of 
Furopyridazinone-Based Molecules (Paper II) 
3.2.1 Introduction 
Apoptosis is regulated by many factors, which are involved in the activation and execution 
of related events (Hengartner, 2000). The Bcl-2 (Bcell lymphoma-2) family of proteins is the 
main regulator of apoptotic process, acting either to promote or inhibit it (Adams, 1998). 
Indeed, this family includes both pro- and anti-apoptotic proteins that should function in 
harmony for a controlled regulation of apoptosis pathways, and their relative levels are critical 
for cells. Overexpression of BCL2 gene, which encodes the antiapoptotic Bcl-2 protein, greatly 
contributes to the resistance of cancer cells to apoptosis, and it has also been reported to play a 
role in the resistance to conventional cancer treatments (Yip and Reed, 2008). Targeting the 
BCL2 gene to inhibit protein expression may be an effective way to prevent the evasion of 
apoptosis in cancer cells and to increase chemotherapeutic efficacy. The human BCL2 gene has 
two promoters: P1, identified as the principal transcriptional promoter, and P2 (Seto et al., 
1988). The P1 promoter and the region upstream thereof, contain G-rich elements that have 
unequivocally been shown to form G4s (Dexheimer et al., 2006). 
A G4-forming sequence that plays a major role in the regulation of BCL2 transcription is 
located directly upstream (~30 bases) from the P1 promoter (Dai et al., 2006). This sequence 
forms a predominant G4 structure (bcl-2) with a distinctive hybrid (3+1) topology having two 
lateral loops (of 3 and 7 nucleotides, respectively), one single-nucleotide propeller loop, and 
four grooves of different widths (Dai et al., 2006) (Figure 3.10). 
 
 
Figure 3.10. Representative model of bcl-2 G4 NMR structure (guanine, green; adenine, red; thymine, blue; 
cytosine, yellow). 
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Several organic molecules have been shown to be able to bind and stabilize bcl-2 G4 with 
subsequent down-regulation of Bcl-2 transcription and expression levels (Feng et al., 2016; 
Jana et al., 2017; Micheli et al., 2016; Wang et al., 2010), thereby demonstrating the real 
potential of the G4-targeting therapeutic approach, which also has the great advantage of 
circumventing the problem of acquired resistance, which is the main limitation of current Bcl-
2-targeted therapeutic strategies.  
Most of the bcl-2 G4 ligands identified so far are characterized by a large, planar aromatic 
core with the capability of stacking on the external G-tetrads, a common element in G4 
recognition (Amato et al., 2014a; Neidle, 2016; Pagano et al., 2015). Therefore, although these 
ligands have shown good G4 over duplex selectivity, they do not exhibit specificity for bcl-2 
versus other G4 structures. Moreover, most of them share unfavorable chemical properties such 
as high molecular weight and/or hydrophobic nature, which result in very poor drug-like 
properties. Therefore, despite being excellent ligands in vitro, the unfavorable 
pharmacokinetics and toxicity due to poor selectivity versus different G4 structures critically 
hamper their advancement in chemotherapy. 
The next goal in G4-based drug design is to enhance the drug-likeness of the ligands and 
their selectivity for a specific structure, so as to permit pathway-specific targeting. The peculiar 
structural features of bcl-2 G4 suggest that specific targeting of such a promoter G4 may, in 
principle, be possible. To discover structurally novel compounds that do not show the 
aforementioned drawbacks, it is necessary to explore a larger chemical space. In this 
perspective, compounds without a large planar aromatic core may be more promising to achieve 
the desired drug-likeness and G4 specificity. 
With the aim of identifying compounds with these properties, in collaboration with Dr. 
Mariateresa Giustiniano (Department of Pharmacy, University of Naples “Federico II”, Italy) 
we decided to exploit the innate ability of multicomponent reactions to generate diversity and 
to explore a large chemical space in short times, for searching new G4-targeting ligands. In 
particular, we designed and synthesized a small series of furopyridazinone-based molecules. 
The pyridazinone nucleus was selected because it is present in a plethora of compounds 
endowed with various biological activities (antihypertensive, antithrombotic, anti-
inflammatory, and anticancer) (Asif, 2012; Prime et al., 2011), and it is considered a privileged 
structure that is currently experiencing a renewed interest in medicinal chemistry. Starting from 
this nucleus, we recently presented an expeditious multicomponent one-pot reaction 
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methodology for generating a small collection of fully substituted furo[2,3-d]pyridazin-4(5H)-
ones (FPs) (Giustiniano et al., 2014, 2015). The facile and efficient synthetic route for the FP 
derivatives is shown in Figure 3.11. 
 
 
Figure 3.11. General synthetic route for the FP derivatives. 
 
This strategy allowed us to readily produce a variety of analogues (1b-11b, Table 3.4) with 
different side arms (in order to avoid confusion, compounds 1-11 in Paper II here appear as 1b-
11b). It is known that side arms can be important in modulating the affinity of G4-targeting 
ligands, as well as in influencing their binding specificity toward different conformations 
(Amato et al., 2016). In addition, their structural features should prevent intercalation into the 
duplex DNA. 
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Table 3.4. Structures of the furopyridazinone derivatives. 
 
Compound R1 R2 -NR3R4 R5 
1b  
   
-COOMe 
2b 
   
-COOMe 
3b 
   
-COOMe 
4b 
   
-COOMe 
5b 
   
-COOMe 
6b 
   
-COOMe 
7b 
 
 
 
-COOMe 
8b 
 
 
 
-COOMe 
9b 
 
 
 
-COOMe 
10b 
   
-COOMe 
11b 
   
-COO-Li+ 
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3.2.2 Results and discussion 
Circular Dichroism studies 
Circular dichroism (CD) spectroscopy and CD-melting experiments were carried out to 
investigate the in vitro binding properties of synthesized FP derivatives for bcl-2 versus other 
G4 structures (Pagano et al., 2012). In addition to bcl-2, two G4-forming sequences from KIT 
(c-kit1) and MYC (c-myc) oncogene promoter regions, and a G4 from the human telomere 
(Tel24) were used in these experiments. The self-complementary duplex-forming dodecamer 
d(CGCGAATTCGCG) (ds12) was also used to estimate the G4 over duplex selectivity of the 
ligands. The structure adopted by each DNA sample was first verified by CD measurements. In 
agreement with the presence of parallel G4 topologies, c-kit1 and c-myc showed a positive band 
at 264 nm and a negative one at 243 nm in the CD spectra. Otherwise, bcl-2 and Tel24 showed 
two positive bands at around 265 and 290 nm and a weak negative band at around 240 nm, in 
agreement with the presence of hybrid structures as major conformation (Figure 3.12). The 
structure of ds12 was also verified by CD, showing the typical spectrum of a duplex DNA 
(Figure 3.12). CD experiments were then performed to determine if compounds 1b–11b alter 
the native folding topology of the investigated DNA structures. Upon addition of each 
compound (4 mol equivalents) to the DNAs (G4s and duplex), no significant alterations of CD 
spectra were observed, thus suggesting an overall preservation of their architectures (Figure 
3.12). 
The DNA stabilizing properties of 1b–11b were evaluated by CD-melting experiments 
measuring the ligand-induced change in the melting temperature (ΔTm) of both G4 and duplex 
structures. The results of these experiments (Table 3.4) show that none of the derivatives 
significantly increase the stability of c-kit1, c-myc and Tel24 G4s, as well as that of ds12 
duplex, thus suggesting their poor ability to bind to those DNA structures (ΔTm ≤ 2.6 °C). 
However, compounds 2b and 3b showed an appreciable enhancement of the stability of bcl-2 
(ΔTm ≥ 3.5 °C). 
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Figure 3.12. CD spectra of the investigated DNAs in the absence and in presence of 4 mol equivalents of 
compounds 1b-10b. 
 
Notably, a non-negligible destabilization of the ds12 duplex occurs with some of these 
compounds. We hypothesize that it may be due to nonspecific interactions of compounds with 
the DNA molecule that might favor single-stranded DNA, resulting in a shift of the folded–
unfolded equilibrium toward the unfolded form during the melting experiment, which, in turn, 
would result in a slight decrease in Tm. 
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Table 3.5. Ligand-induced thermal stabilization of G4 and duplex DNAs 
measured by CD melting experiments. 
ΔTm (°C)a 
Compd bcl-2 c-kit1 c-myc Tel24 ds12 
1bd 1.9 1.1 0.2 0.0 -0.6 
2b 4.0 1.3 0.5 1.4 -1.3 
3b 3.5 0.9 0.0 0.1 -0.4 
4b 2.9 0.8 0.5 0.0 -2.0 
5b 2.3 0.4 1.2 0.0 -0.7 
6b 2.2 0.8 2.0 0.1 -1.2 
7b 2.8 1.1 0.8 0.2 -0.5 
8b 2.3 0.7 1.0 0.1 -2.0 
9b 2.3 1.0 2.6 0.0 -2.0 
10b 1.6 1.0 1.4 0.0 -1.6 
11b 2.9 0.4 2.0 0.1 -1.4 
aΔTm represents the difference in melting temperature [ΔTm = Tm (DNA+4 ligand equiv)- 
Tm(DNA)]. The Tm values of DNAs alone are bcl-2 = 64.8 ± 0.5°C, c-kit1 = 59.8 ± 0.5 
°C, c-myc = 89.3 ± 0.5 °C, Tel24 = 59.5 ± 0.5 °C, ds12 = 69.5 ± 0.5 °C.  
 
Despite compounds 2b and 3b not having shown very potent thermal stabilization effects, 
they exhibited a clear preference for the bcl-2 over the other G4 motifs investigated in this 
study. This suggests that the aromatic furo[2,3-d]pyridazin 4(5H)-one core can, if appropriately 
substituted, actually represent a new molecular scaffold for the specific targeting of BCL2 gene 
promoter.  
 
Fluorescence Studies 
To obtain quantitative data regarding the affinity of 2b and 3b for bcl-2 G4, fluorescence 
titration experiments were performed (Giancola and Pagano, 2013). Fluorescence emission 
spectra of the ligands in the absence and presence of increasing amounts of G4 were recorded. 
The fluorescence intensity of the ligands decreased gradually with addition of DNA until it 
reached saturation (Figure 3.14). The binding curves were obtained by plotting the fraction of 
bound ligands (α), calculated following fluorescence changes at the emission maximum, as a 
function of G4 concentration. The curves were fitted using an independent and equivalent 
binding sites model, by means of nonlinear regression algorithm, giving binding constants (Kb) 
of 1.0 (±0.4) ×106 and 0.6 (±0.2) × 106 M-1 for compounds 2b and 3b, respectively, and a 
stoichiometry of 1:1 in both cases. 
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Figure 3.13. Representative fluorescence emission spectra of A) 2b, and B) 3b (2.5 µm) in the absence and 
presence of stepwise additions (5 µL) of bcl-2-G4 (165 mm) at 25 °C. Insets show the titration curves 
obtained by plotting the fraction of bound ligand (a) versus DNA concentration 
 
Nuclear Magnetic Resonance studies 
NMR spectroscopy was used to obtain indications about the binding mode of two selected 
compounds to bcl-2 (Pagano et al., 2012). According to the literature, under the experimental 
conditions used, the investigated sequence forms a single G4 conformation characterized by 12 
well-resolved imino proton peaks, corresponding to the 12 guanines involved in the three G-
tetrad planes (Figures 3.15 and 3.16) (Dai et al., 2006). Upon addition of increasing amounts of 
2b and 3b to the bcl-2 solutions, gradual chemical shift changes for some G4 proton signals 
were observed. Some signals of the compounds were also detected in the spectra. These peaks 
only grew in intensity, without showing any significant change in chemical shift values by 
increasing ligand concentration, clearly suggesting a rapid binding process on the NMR 
timescale.  
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Figure 3.14. Imino (left) and aromatic (right) regions of the 1D 1H NMR spectra of bcl-2 G4 titrated with 
2b. The ligand equivalents are shown on the left of the spectra. 
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Figure 3.15. Imino (left) and aromatic (right) regions of the 1D 1H NMR spectra of bcl-2 G4 titrated with 
3b. The ligand equivalents are shown on the left of the spectra. 
 
To evaluate the DNA residues involved in the interaction with 2b and 3b, the chemical shift 
variations (Δδ) of bcl-2 were calculated (Figure 3.16). The residues of the G4 structure are 
highlighted with different colors to outline different ranges of Δδ values (green, orange, and red 
for |Δδ| ≤ 0.01, 0.01 < |Δδ| ≤ 0.02, and |Δδ| > 0.02, respectively). Interestingly, both ligands 
were able to induce significant changes in the chemical shift of the aromatic protons of residues 
A10–T16 (except for T15), which form the 7-nucleotide lateral loop of the G4. Moreover, the 
binding of 2b also caused the perturbation of the aromatic signals of G9 and G17, that are very 
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close to the loop. On the other hand, 3b also induced variations of the aromatic protons of G1–
G3 and G22–G23 residues that face into the same groove of bcl-2. All these findings give 
indications that 2b and 3b bind to the target G4 mainly through interactions at the long lateral 
loop and in the groove between the fourth and first parallel G-strands. 
 
Figure 3.16. Chemical shift variations (Δδ) of selected signals of bcl-2 G4 upon addition of compounds (A) 
2b and (B) 3b, and three-dimensional structure of bcl-2 colored according to Δδ values (green, orange, and 
red for |Δδ| ≤ 0.01, 0.01 < |Δδ| ≤ 0.02, and |Δδ| > 0.02, respectively). 
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Biological assays 
In collaboration with Dr. Sonia Di Gaetano and Dr. Domenica Capasso (Institute of 
Biostructures and Bioimaging, CNR, Naples, Italy) biological assays were also performed to 
evaluate the cellular effects of compound 3b, and to see whether it could also interact with the 
G4-forming sequence of BCL2 promoter region in cellulo, and thus decrease gene transcription 
and expression levels. Compound 3b was selected for such further studies because of its higher 
solubility and bcl-2 selectivity over compound 2b. RHPS4, one of the gold-standard ligands for 
G4 affinity and G4 over duplex selectivity (Cheng et al., 2008; Gavathiotis et al., 2001), was 
also tested for comparison. First, the cytotoxic activity of the compound was evaluated in vitro 
on different human cancer cell lines (HepG2, MCF-7, HeLa, WM266, Jurkat) and normal 
human dermal fibroblasts (HDF). The experiments, performed at 10 µm ligand concentration 
for 24 h, showed an interesting cytotoxic activity on all the cancer cell lines examined (Figure 
3.17), with a higher effect (~30% inhibition) observed on Jurkat cells (treated with 10 or 25 µm 
ligand concentration), where BCL2 is known to play a critical role in regulating the survival 
and tumorigenicity of cells (Reed et al., 1990). Remarkably, 3b did not exhibit appreciable 
activity on normal cells. In comparison, RHPS4, used here as a positive control, turned out to 
be more active on all tested tumor cell lines, but it also exhibited a certain degree of toxicity on 
normal cells. This was an expected result in view of its high affinity for G4, which, coupled 
with the lack of selectivity for a specific G4 structure, leads to strong, but more indiscriminate 
cytotoxicity.  
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Figure 3.17. Cytotoxic effect of RHPS4 and 3b on A) HepG2, MCF-7, HeLa, WM266, and HDF cell lines 
treated with 10 µm ligand concentration for 24 h, and B) Jurkat cells treated with the reported 
concentrations for 24 h. The results are presented as the percentage of proliferating cells with respect to 
control (vehicle-treated cells). All data are mean values ±SEM of at least three independent experiments 
performed in triplicate (#p < 0.05). 
 
To determine whether 3b induces apoptosis, Jurkat cells were treated with the compound 
(and with RHPS4 for comparison) and, after 16 h, apoptosis was evaluated with annexin V-
FITC/PI double staining by flow cytometry analysis (Capasso et al., 2014). Results of this 
experiment (Figure 3.18) showed that the cells treated with 3b exhibited 30% early apoptotic 
cells with respect to the control; in contrast, for RHPS4, the entire population of cells was found 
to be in the late apoptotic state. To determine the effect of 3b on BCL2 gene transcription, 
quantitative analysis of mRNA was carried out by means of real-time PCR. Upon treatment of 
Jurkat cells with 25 µm of compound 3b for 24 h, a significant decrease (~24%) in BCL2 mRNA 
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was observed (Figure 3.18). In parallel, to confirm that the observed decrease in mRNA levels 
leads to a decrease in Bcl-2 protein, western blot analysis was performed by using an anti-Bcl-
2 antibody. These experiments showed that treatment with 3b results in a substantial decrease 
(~40%) in the level of Bcl-2 protein, in agreement with results obtained by qPCR. Similar 
results were obtained in both analyses with RHPS4 (Figure 3.18). 
 
 
Figure 3.18. Apoptosis analysis with annexin V-FITC/PI double staining on Jurkat cells treated with A) 
vehicle, B) 3b and C) RHPS4 (25 µM). For all panels: upper left quadrants, necrotic cells; upper right, 
advanced apoptotic cells; lower left, viable cells; lower right, early apoptotic cells. These results are 
representative of three independent experiments. D) qPCR analysis of BCL2 mRNA levels in Jurkat cells. 
Results are presented as fold change in gene expression relative to the reference gene (GAPDH). Data were 
analyzed using the 2-ΔΔCt method (Livak and Schmittgen, 2001). S.E.=standard error. C.V.=percent 
coefficient of variation of 2-ΔΔCt. E) Western blot analysis of lysates from Jurkat cells treated with (1) vehicle, 
(2) RHPS4, and (3) 3b (25 µM) for 24 h. Specific anti-Bcl-2 antibody was used to detect Bcl-2 protein; actin 
was used as a control. The blot is representative of three experiments with similar results. 
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3.2.3 Conclusions 
In this study, a series of FP derivatives were evaluated as G4-targeting compounds. Among 
them, two derivatives were shown to selectively stabilize the G4-forming sequence derived 
from the promotor region of the BCL2 gene. The binding of the two selected compounds to the 
bcl-2 G4 was characterized by means of fluorescence and NMR titration experiments. 
Moreover, one of such ligands effectively down-regulated the transcription and expression of 
BCL2 in Jurkat cells, inducing a significant increase of the percentage of cells in an early 
apoptotic state. All these experimental results reinforced the idea of inhibition of Bcl-2 
expression through the specific targeting of bcl-2 G4 DNA and provided clear evidence that FP 
derivatives represent a new class of drug-like compounds useful to this aim, thus stimulating 
further studies aimed at developing more potent derivatives as effective pathway-specific 
anticancer agents. 
 
3.2.4 Experimental Section 
Oligonucleotide synthesis and sample preparation 
The DNA sequences were synthesized using standard β-cyanoethylphosphoramidite solid 
phase chemistry on an ABI 394 DNA/RNA synthesizer (Applied Biosystem) at the 5 μmol 
scale. DNA detachment from support and deprotection were performed by treatment with 
concentrated ammonia aqueous solution at 55 °C for 12 h. The combined filtrates and washings 
were concentrated under reduced pressure, dissolved in water, and purified by high-
performance liquid chromatography (HPLC) on a Nucleogel SAX column (Macherey- Nagel, 
1000−8/46), using buffer A consisting of 20 mM KH2PO4/ K2HPO4 aqueous solution (pH 7.0), 
containing 20% (v/v) CH3CN, buffer B consisting of 1 M KCl, 20 mM KH2PO4/K2HPO4 
aqueous solution (pH 7.0), containing 20% (v/v) CH3CN, and a linear gradient from 0% to 
100% B for 30 min with a flow rate 1 mL/min. The fractions of the oligomers were collected 
and successively desalted by Sep-pak cartridges (C-18). The isolated oligomer was proved to 
be >98% pure by NMR. In particular, the following DNA sequences have been synthesized: 
the bcl-2 promoter sequence d(GGGCGCGGGAGGAATTGGGCGGG) (bcl-2) (Dai et al., 
2006), the KIT oncogene promoter sequence d(AGGGAGGGCGCTGGGAGGAGGG) (c-kit1) 
(Phan et al., 2007b), the modified nuclease hypersensitivity element III1 sequence 
d(TGAGGGTGGGTAGGGTGGGTAAGG) of the MYC promoter (c-myc) (Ambrus et al., 
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2005), the modified human telomeric sequence d(TTGGGTTAGGGTTAGGGTTAGGGA) 
(Tel24) (Luu et al., 2006a), and the self-complementary duplex forming dodecamer 
d(CGCGAATTCGCG) (ds12). DNAs were prepared in the appropriate buffer (bcl-2: 20 mM 
potassium phosphate, 40 mM KCl; c-kit1: 20 mM potassium phosphate, 50 mM KCl; c-myc 
and Tel24: 20 mM KH2PO4, 70 mM KCl; ds12: 10 mM Li3PO4, 100 mM KCl) at pH 7.0. The 
concentration of oligonucleotides was determined by UV adsorption measurements at 90 °C 
using molar extinction coefficient values ε (λ = 260 nm) calculated by the nearest neighbor 
model (Cantor et al., 1970). Samples were heated at 90 °C for 5 min, and then gradually cooled 
to room temperature overnight. 
 
Circular dichroism spectroscopy 
Circular dichroism (CD) experiments were recorded on a Jasco J-815 spectropolarimeter 
equipped with a PTC-423S/15 Peltier temperature controller. All the spectra were recorded at 
20 °C in the wavelength range of 230−360 nm and averaged over three scans. The scan rate 
was set to 100 nm/min, with a 1 s response time and 1 nm bandwidth. Buffer baseline was 
subtracted from each spectrum. For the CD experiments, 10 µM G4 DNAs and 15 µM duplex 
were used. CD spectra of DNA/ligand mixtures were obtained by adding 4 mol equivalents of 
ligands (stock solutions of ligands were 10 mM in DMSO). CD melting experiments were 
carried out in the 20−100 °C temperature range at 1 °C/min heating rate, by following changes 
of CD signal at the wavelengths of the maximum CD intensity. CD melting experiments were 
recorded in the absence and presence of ligands (4 mol equivalents) added to the folded DNA 
structures. The melting temperatures (Tm) were determined from curve fit using Origin 7.0 
software. ΔTm values were determined as the difference in the melting temperature of DNA 
structures with and without ligands. All experiments were performed in triplicate and the values 
reported are average of three measurements. 
 
Fluorescence Titration experiments 
Fluorescence experiments were performed at 20 °C on a FP-8300 spectrofluorimeter (Jasco) 
equipped with a Peltier temperature controller accessory (Jasco PCT-818). A sealed quartz 
cuvette with a path length of 1 cm was used. Both excitation and emission slits were set at 5 
nm. The titrations were carried out by stepwise addition (5 µL) of DNA solutions (165 µM) to 
a cell containing a fixed concentration (2.0–2.5 µM) of ligand solution. Compounds 2b and 3b 
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were excited at 377 and 287 nm, respectively, and emission spectra were recorded in the range 
of 385-600 nm for 2b and 325-600 nm for 3b. After each addition of DNA, the solution was 
stirred and allowed to equilibrate for 5 min. The fraction of bound ligand (α) at each point of 
the titration was calculated following fluorescence changes at the maximum of intensity, as 
previously reported (Moraca et al., 2017; Pagano et al., 2015). Titration curves were obtained 
by plotting a versus the DNA concentration. The equilibrium binding constants (Kb) were 
estimated from this plot by fitting the resulting curve to an independent and equivalent binding 
site model (Moraca et al., 2017; Pagano et al., 2015). The experiments were repeated three 
times, and the obtained results are presented as the mean ± S.D. 
 
Nuclear Magnetic Resonance 
NMR spectra were recorded on a Varian Unity INOVA 700 MHz spectrometer. One-
dimensional proton spectra of samples in H2O were recorded using pulsed-field gradient 
DPFGSE for H2O suppression. The bcl-2 DNA sample was prepared at a concentration of 0.2 
mM in 0.6 mL (H2O/D2O 9:1) buffer solution containing 20 mM KH2PO4, 40 mM KCl, 0.2 
mM EDTA, at pH 7.0. Aliquots of ligand stock solutions in deuteron-DMSO were added 
directly to the DNA solution inside the NMR tube. The NMR data were processed on iMAC 
running iNMR software (www.inmr.net). 
 
Cell Lines and Culture Conditions 
Human adenocarcinoma (HeLa), human liver cancer (HepG2), breast cancer (MCF-7) cell 
lines, and human normal dermal fibroblasts (HDF) were grown in DMEM supplemented with 
10% fetal bovine serum (FBS), 1% glutamine, 100 U/mL penicillin, and 100 µg/mL 
streptomycin (Euroclone, Italy). Human metastatic melanoma cell line (WM266) and human T 
lymphoblastoid cell line (Jurkat) (ATCC, USA) were grown in RPMI, supplemented with heat-
inactivated 10% fetal bovine serum (FBS), 1% glutamine, 100 U/mL penicillin, and 100 µg/mL 
streptomycin. The cells were maintained in humidified air containing 5% CO2 at 37 °C. 
 
Cell Proliferation Assay 
WM266, MCF-7 and HepG2 cells were plated at a density of 1 × 104 cells/100µL, HeLa and 
HDF at density of 7 × 103 cells/100µL, on 96-well plates in medium 10% FCS. 10 µM of each 
ligand, or DMSO as vehicle, were added to the cells. After 24 h incubation at 37 °C, cell 
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viability was assessed by performing MTT (Sigma Aldrich, Italy) reduction inhibition assay. 
Jurkat cells were seeded on a 96-well plate at a density of 1 × 104 cells/100µL and incubated 
for 24 h with 10 or 25 µM of RHPS4 or compound 3b, respectively. After incubation, 0.4% 
Trypan Blue was added to the cell suspension and cell numbers were estimated by counting 
under a light microscope. Cells stained blue were considered non-viable (Di Gaetano et al., 
2001). Cytotoxicity experiments were independently performed at least three times. Statistical 
significance between groups was assessed by Student’s t-test. Data are expressed as means 
standard error (S.E.) p values < 0.05 were considered to be statistically significant. 
 
Apoptosis Assay 
The apoptosis assay was performed on Jurkat cells seeded at 1 × 106 cells/mL in a 6-well 
plate. The cells were incubated at 37 °C with ligands at 10 or 25 µM concentration and apoptosis 
was analyzed after 16 h by double staining with annexin V/FITC and Propidium iodide (PI) 
(eBioscience, USA) (Capasso et al., 2014, 2017). The percentage of cell undergoing apoptosis 
or necrosis was quantified using a flow cytometer equipped with a 488 nm argon laser (Becton 
Dickinson, USA) by Cell Quest software. All FACS analyses were performed at least 3 times.  
 
Western Blotting  
Jurkat cells were analyzed 24 h after treatment with compounds at 25 µM concentration. 
Whole cell lysates were obtained by using lysis buffer (50 mM Hepes pH 7.4, 50 mM NaCl, 
1% Triton) supplemented with protease inhibitor cocktail (Roche, Italy). Cell lysates were 
incubated on ice for 30 min and then centrifuged at 13,000 rpm for 30 min to remove cell debris. 
Protein concentrations were determined by Bradford method using Bio-Rad reagent (BioRad 
Laboratories, Italy). Proteins (100 µg) were resolved by SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE) and transferred to a PVDF membrane (Bio-Rad). The membrane 
was probed with the primary antibody (anti-Bcl-2 antibody from Bethyl, USA) o.n. at 4 °C. 
Proteins were visualized with an enhanced chemiluminescence detection system (Euroclone) 
and images were acquired with ChemiDoc XRS System (Bio-Rad Laboratories, Italy) and 
analyzed with the QuantityONE software.  
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RT-PCR and qPCR.  
Total RNA was isolated from treated cells using TRI Reagent (Sigma Aldrich). Reverse 
transcription was performed using 0.5 µg of total RNA, 200 U of MMLV Reverse Transcriptase 
RNase H- (Euroclone), dNTPs, random primers, RNase inhibitor. Reaction temperature was set 
at 42 °C for 60 min. After reverse transcription, qPCR assay was carried out using the following 
primers: GAPDH forward d(AACGGGAAGCTTGTCATCAATGGAAA), GAPDH reverse 
d(GCATCAGCAGAGGGGGCAGAG), BCL-2 forward 
d(CTGCACCTGACGCCCTTCACC), BCL-2 reverse 
d(CACATGACCCCACCGAACTCAAAGA) (Sigma-Genosys, UK). The amplification 
reactions were run in duplicate. Real-time quantitative PCR (qRT-PCR) amplifications were 
performed using the SYBR Premix Ex Taq II (Takara, Japan) in Rotor-gene Q (Qiagen, Italy). 
The qRT-PCR protocol was as follows: 95 °C for 15 min followed by 40 cycles of 95 °C for 15 
s, 59 °C for 30 s, and 72 °C for 30 s. Results were expressed as relative fold induction of the 
target genes relative to the reference gene. Calculations of relative expression levels were 
performed using the 2-ΔΔCt method (Finetti et al., 2012; Livak and Schmittgen, 2001; Pane et 
al., 2016), and averaging the values of at least three independent experiments. 
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3.3 Tailoring a lead-like compound targeting multiple G-quadruplex 
3.3.1 Introduction  
Improving selectivity and concomitantly reducing toxicity of chemotherapeutic agents is one 
of the hottest challenges in anticancer research (Liu et al., 2017; Musumeci et al., 2016; 
Nussbaumer et al., 2011; Wheate et al., 2010). Understanding the molecular mechanisms 
involved in growth and proliferation of cancer has allowed developing therapies that efficiently 
act on specific cancer cell processes, not damaging normal cells and thus reducing typical side 
effects of anticancer drugs (Baudino, 2015; Gao et al., 2015; Huang et al., 2014; Musumeci et 
al., 2017b; Platella et al., 2017b; Viswanadha Vijaya Padma, 2015). Thus, compounds able to 
target G4 structures and discriminate duplex DNA can in principle act as effective candidate 
antitumor drugs by interfering with cancer onset and progression pathways without impairing 
healthy cells. In addition, by simultaneously targeting multiple G4 structures located in 
regulatory regions of different oncogenes or at telomeres, these binders could produce multiple 
inhibitory activities, promoted by a unique general mechanism of action, resulting into valuable 
synergistic effects. 
With a view to expanding the repertoire of available drug-like G4 binders and speeding up 
the search for true hits, computer-aided virtual screening (VS) can be a valid tool, especially 
for analyzing large libraries of putative ligands (Ma et al., 2012). In this frame, some of us 
previously performed a virtual screening of a 6000 compounds library – obtained from a 
commercially available database – against the tetramolecular, parallel G4 formed by the 
d(TGGGGT) sequence (Cosconati et al., 2009). Among these compounds, six were found to be 
good G4 binders (Figure 3.19), as also confirmed by NMR studies. These ligands were 
subsequently studied in their interaction with different G4s using a variety of biophysical 
techniques (Pagano et al., 2015). Remarkably, two of these compounds (2c and 4c, Figure 3.19) 
showed selective G4-stabilizing properties, as well as ability to induce DNA damage response 
and telomere-dysfunction-induced foci (TIFs) in the µM range. In particular, compound 4c was 
shown to effectively stabilize both telomeric and extra-telomeric parallel G4s, also inducing G4 
formation in some of the investigated G-rich oligonucleotides in the absence of cations (Pagano 
et al., 2015). 
Encouraged by the promising activity of compound 4c, here we identified and analyzed a 
small focused library of its structural analogs, featured by different pendant groups on the N-
atom of the oxazine ring, with the aim of developing more potent and selective ligands 
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efficiently targeting multiple G4 structures. First, the selected molecules have been tested vs. 
topologically different G4s by means of the G4-CPG assay, an affinity chromatography-based 
method we have recently developed for the rapid screening of putative G4 ligands (Platella et 
al., 2018). Then, the G4-binding properties of the most promising analogs of this library – 
according to the results of the G4-CPG assay – have been investigated in detail employing both 
biophysical and biological tools. 
 
 
Figure 3.19. Chemical structures of compound 1c-6c (in order to avoid confusion, compounds 1-6 in Paper 
III here appear as 1c-6c) previously selected from a commercially available database by structure-based 
virtual screening. 
 
3.3.2 Results and discussion  
Selection of compound 4c analogs 
A convenient strategy for the discovery of G4-selective ligands with enhanced 
activity/toxicity ratio can be to start from a known lead compound featured by a suitable core, 
and then functionalize it with a set of different decorations. In this way, the interactions with 
the target G4s ensured by the core are preserved, and improved affinity (and/or selectivity) can 
be achieved by exploiting additional interactions (i.e., electrostatic, stacking, and/or hydrogen 
bonding interactions) realized by the decorations. Following this strategy, using 4c as the lead 
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compound we here aimed at identifying a set of its analogs featured by the furobenzoxazine 
naphthoquinone core and bearing different pendant groups on the oxazine N-atom. 
Given the relative synthetic accessibility of pentacyclic furobenzoxazine naphthoquinones, 
we first searched for analogs of 4c available in commercial molecular databases. This approach 
has the advantage of quickly providing a library of structural analogs of the lead compound and 
being cost-effective. Therefore, the Dice similarity coefficient was computed between 4c and 
the compounds present in the ZINC database collection of commercially available compounds 
(https://zinc15.docking.org) setting the similarity threshold to 70%. This search resulted in 40 
compounds including, as desired, a number of furobenzoxazine-containing naphthoquinone 
derivatives, as well as species exhibiting different scaffolds. Ten furobenzoxazine 
naphthoquinone derivatives obtained from the filtered database were thus selected (S4-1–S4-
10, Table 3.5), along with one furonaphthoxazine analog (D4, Table 3.5), included in this study 
as a representative example of a different scaffold. 
 
Table 3.6. Chemical structures of the here investigated compounds. 
                       D4 
Compound R Compound R 
4c 
 
S4-6 
 
S4-1 
 
S4-7 
 
S4-2 
 
S4-8 
 
S4-3 
 
S4-9 
 
S4-4 
 
S4-10 
 
S4-5 
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G4-CPG assay and selection of the model G4- and duplex-forming oligonucleotide sequences 
We recently realized a functionalized CPG support, designed for the High Throughput 
Screening of G4 ligands by affinity chromatography, named G4-CPG (Platella et al., 2018; 
Platella and Al.). This support has been conceived to allow the on-line synthesis of the G4-
forming oligonucleotides, as well as the successive binding assays with the potential ligands, 
providing quick, reliable results. Indeed, in contrast to commercially available supports 
previously used for affinity chromatography of oligonucleotides, 
(http://www.glenresearch.com/Technical/TB_OAS.pdf; Musumeci et al., 2014, 2017a) the new 
derivatized CPG has low-to-null unspecific interactions with G4 ligands. Thus the binding 
assays on the G4-CPG provide clean and reproducible data, well reflecting the affinity trend of 
the tested molecules vs. G4 targets in solution (Platella et al., 2018). 
In brief, the G4-CPG assay is based on affinity chromatography screenings, realized on a 
suitably modified CPG support functionalized with the G-rich oligonucleotide of interest, 
reproducing the target G4-forming DNA tract. Being bound to the CPG support via a long and 
flexible linker, it can fold in its preferred conformation under various solution conditions and 
retain high-affinity ligands, thus allowing their easy identification. Indeed, using a fluorescent 
ligand differently responding to the interaction with various G4 topologies, (Zuffo et al., 2017) 
we already proved that the G4-forming oligonucleotides linked to the CPG support preserve 
their native conformation as in solution (Platella et al., 2018).  
Thus, aiming at expanding the use of the G4-CPG assay to a wide variety of topologically 
different G4 structures, we here functionalized the CPG support with a set of biologically 
relevant G4-forming oligonucleotides. In detail, we selected the following DNA sequences: a) 
the 26-mer d[(TTAGGG)4TT] (Tel26) as a well-studied model of the 3′-overhang of the human 
telomeric DNA (Dai et al., 2007); b) the 33-mer 
d(TGGGGAGGGTGGGGAGGGTGGGGAAGGTGGGGA) (c-myc) from the nuclease 
hypersensitive element in the human MYC promoter, containing six G-rich tracts of unequal 
length and characterized by a remarkable polymorphism (Simonsson et al., 2000; Sun and 
Hurley, 2009), of which typically only shorter and modified variants have been used as models 
(Mathad et al., 2011); c) the 22-mer d(AGGGAGGGCGCTGGGAGGAGGG) (c-kit1) - of 
which both the NMR (Phan et al., 2007a) and crystal structures (Wei et al., 2012, 2015) have 
been solved revealing a unique topology - and the 21-mer 
d(CGGGCGGGCGCGAGGGAGGGG) (c-kit2) - which, depending on the K+ concentration, 
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adopts two distinct parallel-stranded G4 scaffolds in solution (Kuryavyi et al., 2010) - both from 
the human KIT promoter; d) the 24-mer d(AAGGGGAGGGGCTGGGAGGGCCCGGA) 
(hTERT1) from the G-rich region in the hTERT core promoter, which represents the main 
regulatory element of the hTERT gene (Chaires et al., 2014; Palumbo et al., 2009). Furthermore, 
in order to probe the ability of the studied compounds to discriminate G4 vs duplex DNA, the 
CPG support has been also functionalized with a 27-mer here named ds27 (Musumeci et al., 
2017a; Platella et al., 2018). Consisting of two Dickerson 12-mer tracts, 
d(CGCGAATTCGCG), i.e. one of the best characterized models of B-DNA duplex, (Drew et 
al., 1981) connected by a TTT loop, ds27 can in fact fold into a stable hairpin duplex and has 
been thus selected as a representative model for a duplex DNA tract. 
 
Experimental screenings by the G4-CPG assay 
The binding assays on the functionalized CPG supports have been performed following 
previously reported procedures (Musumeci et al., 2014, 2017a; Platella et al., 2018), with 
minimal modifications as described in the Experimental section in this Chapter. All the 
oligonucleotide-functionalized supports have been first tested in their ability to bind a set of 
known G4 ligands with different affinity for G4s. In particular, thiazole orange (TO) and 
resveratrol have been used as representative molecules, being respectively a strong and a very 
weak G4 binder (Monchaud et al., 2008; Platella et al., 2017a). The obtained data, showing high 
affinity (bound ligand > 97%) for TO and very low affinity (bound ligand < 4%) for resveratrol 
on all the tested supports, verified the efficacy of the functionalized CPG supports. 
A stock solution of each ligand has been prepared by dissolving a weighed amount of the 
solid compound in pure DMSO; only compound S4-1 proved to be not completely soluble in 
DMSO at the concentration required for the binding assays and was therefore discarded. All the 
other compounds as well as compound 4c proved to be well soluble in the washing/releasing 
solutions used in the binding assays (see Experimental Section of this Chapter) and at the 
concentration chosen for the binding experiments. After solubility checks, we verified the 
absence of unspecific binding on the solid support by incubating the tested compounds with the 
non-functionalized CPG (here named nude CPG, Figure 3.20). Low-to-null unspecific 
interactions with the nude solid support have been observed (Table 3.7), thus further proving 
that nude CPG is essentially inert in these assays, as demonstrated for known G4 
ligands,(Platella et al., 2018) and confirming the general reliability of the method. 
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Figure 3.20. Chemical structures of: (A) commercially available Long Chain AlkylAmine-CPG (LCAA-
CPG) and (B) LCAA-CPG functionalized with 5’-O-DMT, 3’-O-acetyl-thymidine through a hexaethylene 
glycol spacer (nude CPG). 
 
Finally, all the new putative ligands have been tested on the G4s- and hairpin duplex-
functionalized CPG supports. The results of the binding assays, summarized in Table 3.7, 
showed that all the analyzed ligands had good affinity for Tel26 immobilized on the solid 
support. However, no marked improvement was found with respect to 4c, still the best binder 
in the series when tested on this G4-forming sequence, with the only exception of S4-4, showing 
comparable results as 4c. In contrast, when tested on c-myc, compounds S4-2, S4-4, S4-7, S4-
8 and S4-10 displayed higher affinity than 4c. As far as c-kit1 is concerned, almost all the tested 
compounds proved to be stronger binders than compound 4c, with the sole exception of S4-3. 
In the case of c-kit2, S4-2, S4-4, and S4-10 showed higher binding abilities than 4c. Notably, 
also in this case compound S4-3 was the weakest binder of the series. Finally, for hTERT1 all 
the tested analogs had comparable or higher affinity than 4c. 
Noteworthy, all the examined compounds were found to be effective G4 ligands, some of 
which even better than lead compound 4c. Among all the tested compounds, D4 was the worst 
G4 ligand, evidencing that its polycyclic core, different from the other tested molecules, is not 
suitable for G4 targeting. On the other hand, compound S4-4 was the strongest G4 binder of 
the series, able to tightly interact with all the investigated G4s. Overall, although the here 
screened compounds are able to bind all the investigated G4s, thus behaving as multi-target 
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ligands, the highest percentages of binding have been found for c-myc, emerging as the best 
target of the series. 
In order to evaluate the G4s vs. duplex DNA selectivity, all the compounds have been also 
tested in their interaction with ds27, i.e. the hairpin duplex-forming oligonucleotide. Overall, 
most of the ligands proved to effectively discriminate G4- vs. duplex-forming oligonucleotides. 
In particular, S4-4 and S4-5 showed a significantly lower affinity for ds27 than 4c. Remarkably, 
S4-5 gave null affinity for duplex DNA, thus emerging as the most promising analog in terms 
of G4 vs. duplex selectivity on the basis of this binding assay. 
 
Table 3.7. Binding assay results for the investigated compounds on nude and functionalized CPG supports. 
Compound 
Bound ligand (%)a 
Nude 
CPG 
CPG-
Tel26 
CPG-
c-myc 
CPG-
c-kit1 
CPG-
c-kit2 
CPG-
hTERT1 
CPG-
ds27 
4c   0 86 86 70 82 74 18 
S4-2   0 80 94 85 91 82 46 
S4-3   0 73 84 55 67 73 16 
S4-4   0 86 93 90 92 91   2 
S4-5   0 80 84 78 80 82   0 
S4-6 10 80 87 76 83 78 12 
S4-7 11 80 89 77 84 92 33 
S4-8   0 78 90 88 83 87 20 
S4-9   5 75 73 72 68 76 16 
S4-10   0 79 94 90 88 89 28 
D4   7 76 74 75 70 78 22 
aBound ligand is calculated as a difference from the unbound ligand, recovered with 50 mM KCl/10% DMSO/10% ethanol 
washing solution, and expressed as % of the amount initially loaded on the support. Errors associated with the % are within 
± 2%. 
 
Biological activity studies 
Following the binding assays, the G4 ligands have been subjected to biological analyses 
aimed at identifying derivatives with potent and selective DNA damage response (DDR) and 
antitumoral activity. Thus, BJ-EHLT cells – a human foreskin-derived fibroblast cell line, 
expressing the human telomerase reverse transcriptase (hTERT) and SV40 early region – were 
treated for 24 h with 0.5 µM of each compound and the DNA damage was evaluated. To 
appreciate possible improvements in terms of biological activity of the analogs over lead 
compound 4c, we used a time and dose that had been previously optimized for 4c, able to induce 
a slight DNA damage (Pagano et al., 2015). Immunofluorescence (IF) analysis showed relevant 
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amounts of the phosphorylated form of histone H2AX (γH2AX), a hallmark of DNA double-
strand breaks,(Thiriet and Hayes, 2005) evidencing that all the tested ligands – with the sole 
exception of D4, S4-9, and S4-10 – induced similar DNA damage extent as the lead compound 
(Figure 3.21A). In parallel, we also evaluated whether the induced DNA damage – or at least 
part of it – was located at the telomeres. To address this issue, we performed co-staining IF 
experiments using antibodies against γH2AX and TRF1 – an effective marker for interphase 
telomeres – and the co-localization spots, reported as Telomere Induced Foci (TIF), (Takai et 
al., 2003) were evaluated (Figure 3.21B). 
Notably, quantitative analysis confirmed and reinforced the previous observations, 
evidencing that all the compounds (with the only exception of D4, S4-9, and S4-10) induced a 
percentage of TIF positive cells (cells with at least 4 co-localization spots) and average number 
of TIFs per cell similar to lead compound 4c (Figure 3.21C). These data are consistent with the 
comparable affinities of compound 4c and its analogs towards the telomeric model sequences 
found using the G4-CPG assay. 
Next, to test the antitumor efficacy of compound 4c analogs, the cell colony-forming ability 
of the human cervical cancer cells, HeLa, untreated or treated with the different compounds, 
was evaluated. To set up the optimal dose of the drug, we first performed a dose-response 
experiment by using three different concentrations (0.5, 1 and 2 µM) of 4c; the 2 µM 
concentration proved to be the minimal effective dose and was thus selected for testing all the 
other derivatives (Figure 3.22A). Interestingly, cell survival experiments evidenced that 
derivatives S4-4, S4-6, S4-8, and S4-10, despite their high affinity for G4 structures in vitro 
(Table 3.7), were less effective than 4c in affecting tumor cell viability (Figures 3.22B and C). 
Compounds D4 and S4-3 also showed an antiproliferative activity lower than compound 4c 
(Figures 3.22B and C), which could be related, in this case, to an overall G4-affinity lower than 
compound 4c (Table 3.7). 
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Figure 3.21. Compound 4c analogs induce telomeric DNA damage. BJ-EHLT fibroblasts were untreated 
(CTR, white bar) or treated for 24 h with 4c (black bar) and the indicated analogs (light-grey bars) at 0.5 
μM concentration. Cells were processed for immunofluorescence (IF) using antibodies against γH2AX and 
TRF1 to visualize the DNA damage and telomeres, respectively. (A) Percentages of γH2AX-positive cells. 
(B) Representative merged images of IF of untreated and treated BJ-EHLT cells; γH2AX spots in green, 
TRF1 spots in red and nuclei in blue. Enlarged views of Telomere Induced Foci (TIFs) are reported on the 
right panels of each picture. The images were acquired with a Leica Deconvolution microscope 
(magnification 63x). (C) Quantitative analysis of TIFs. The graph represents the percentages of TIF-positive 
cells (bars) and the mean number of TIFs for cell (red line) in the indicated samples. Cells with at least four 
γH2AX/TRF1 foci were scored as TIF positive. Histograms show the mean values ±S.D. of three 
independent experiments. 
 
 
Conversely, the potent cytotoxic activity observed for derivatives S4-2, S4-7 and S4-9 
(Figures 3.22B and C) might be attributed to G4-independent, off-target effects since these 
ligands have shown either a good affinity also for duplex DNA (S4-2 and S4-7) or, in the case 
of S4-9, an affinity towards G4 structures generally lower than other analogs (Table3.7). In 
summary, ligand S4-5 emerged as the most interesting ligand of the series. Indeed, its high 
affinity for G4 - despite an antitumor activity only slightly superior to lead compound 4c - 
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associated with null affinity for duplex DNA (Table 3.7) suggests a promisingly improved 
target specificity compared to the starting compound. 
 
 
 
 
Figure 3.22. Anti-tumor efficacy of compound 4c analogs. (A) Clonogenic activity of human cervical cancer 
cells, HeLa, untreated (CTR, white bar) or treated with 4c at the indicated doses. Surviving fractions were 
calculated as the ratio of absolute survival of the treated sample/absolute survival of the untreated sample. 
(B) Clonogenic activity of HeLa cells, untreated (CTR, white bar), treated with 4 (black bar) or the indicated 
analogues (light-grey bars) at 2 μM dose. Surviving fractions were calculated as reported in A. (C) 
Representative images of the clonogenic assay described in B. Histograms show the mean values ±S.D. of 
three independent experiments. 
 
 
Next, in order to evaluate the selectivity of S4-5 in cell, the effects of this compound have 
been tested also on normal cells. Briefly, human immortalized BJ fibroblasts (BJ-hTERT) have 
been treated with 4c or S4-5 at 1 and 2 µM concentrations and, after 6 days, the number of 
viable cells has been evaluated. Notably, these experiments clearly evidenced that the cytotoxic 
effects of ligand S4-5 on normal cells are definitely lower than those produced by compound 
4c (Figure 3.23A). Moreover, IF analysis of γH2AX evidenced that S4-5, in contrast to 4c, was 
unable to induce an appreciable DNA damage in normal cells (Figures 3.23B and C). Overall, 
these data unambiguously indicated that S4-5 has a much higher selectivity in killing cancer 
cells than compound 4c, making it a promising candidate drug. 
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Figure 3.23. S4-5 analog does not affect normal cells. (A) Human immortalized fibroblasts (BJ-hTERT) 
were treated with compound 4c or derivative S4-5 at the doses of 1 and 2 µM for 6 days. Viable cell number 
was determined by the Trypan Blue exclusion test. (B) BJ-hTERT were treated with 4c or S4-5 at the 1 µM 
dose for 24 h and processed for IF using antibodies against γH2AX. The histogram represents the 
percentages of γH2AX-positive cells. (C) Representative merged images of IF: γH2AX spots in green and 
nuclei in blue. Histograms show the mean values ±S.D. of three independent experiments. 
 
 
CD and CD-melting experiments 
Based on the above discussed results, we investigated by CD experiments in solution the 
ability of S4-5 to interact with a human telomeric G4 (Tel26), an extra-telomeric G4 (c-myc), 
and a duplex structure (ds27), in comparison with 4c. In particular, among the extra-telomeric 
G4s here studied, we chose c-myc since S4-5, as well as the other here tested ligands, has shown 
a slight preference for this G4 structure compared to the others.  
CD-monitored titrations have been performed by adding increasing amounts of the tested 
ligands to samples of these oligonucleotides (2 µM) in 20 mM KCl - 5 mM KH2PO4 - 10% 
buffer (pH 7). As expected in these buffer conditions, Tel26 folded into a hybrid II-type G4 
featured by a maximum at 290 nm and a shoulder at 270 nm (Karsisiotis et al., 2011), c-myc 
formed a parallel G4 with a maximum at around 263 nm (Mathad et al., 2011; Sun and Hurley, 
2009), while ds27 showed the characteristic positive band at 280 nm accompanied by a 
minimum at 251 nm, typical of a B-DNA duplex structure (Figure 3.24) (Kypr et al., 2009). In 
the case of Tel26, an increase of the intensity of the 290 nm band along with the reduction of 
the shoulder at 270 nm have been observed upon adding increasing amounts of S4-5 in solution 
(Figure 3.24A), thus suggesting that some interaction took place. In the titration experiments 
with c-myc, the addition of S4-5 produced only weak changes, with a slight reduction of the 
263 nm band and an increase of the 288 nm band (Figure 3.24B).  
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Fig. 3.24. Effect of S4-5 on the overall conformation of the DNA structures. CD spectra of 2 µM solutions of 
Tel26 (A), cmyc (B) and ds27 (C) in 20 mM KCl - 5 mM KH2PO4 - 10% DMSO buffer (pH 7) in the absence 
and presence of increasing amount of S4-5 (up to 5 mol equivalents). 
 
In contrast, in the titration of ds27 no detectable change in the CD profile of the duplex has 
been observed, suggesting that this structure was essentially unaffected by the addition of even 
a large excess of ligand (Figure 3.24C). 
A similar behavior has been found in the titrations of both the G4s and the duplex with 4c 
(Figure 3.25). In all cases, up to 5 equivalents of ligand have been added to the oligonucleotide 
solutions, as the best compromise between solubility of the analyzed ligands and saturation of 
the oligonucleotide CD signals. No induced CD signal has been detected for all the investigated 
systems in the range 320-800 nm (Figure 3.25). 
CD-melting experiments have been performed for all the oligonucleotide/ligand mixtures to 
evaluate if stabilizing or destabilizing effects on the G4 and hairpin duplex structures were 
obtained upon incubation with 4c and S4-5. CD melting curves of Tel26, c-myc and ds27 in the 
absence or presence of each ligand (at 5:1 ligand/DNA ratio) have been recorded by following 
the CD signal changes at the wavelength of their intensity maximum (290, 263, and 251 nm for 
Tel26, c-myc and ds27, respectively). 
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Figure 3.25. CD titrations of Tel26, c-myc and ds27 (top, middle and bottom, respectively) with increasing 
amounts of S4-5 (left panels) and 4c (right panels). 
 
The results of the CD melting experiments showed that compounds S4-5 and 4c did not 
significantly affect the stability of the Tel26 and ds27 structures (Table 3.8), even if for Tel26 
the drop of CD signal between 20 and 90 °C was much higher in the presence of the ligands 
than in their absence. Conversely, both ligands appreciably stabilized the c-myc G4 structure 
('Tm > 8 °C).  
Overall, these results confirmed the ability of the here investigated pentacyclic scaffold to 
significantly stabilize parallel G4s, not affecting the thermal stability of other G4 conformations 
and duplex DNA (Pagano et al., 2015). 
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Table 3.8. Melting temperatures (Tm) of tel26, cmyc and ds27 
in the absence or presence of ligands (5 equiv) measured by 
CD melting experiments. 
Ligand 
Tm (°C) (±1) 
Tel26 c-myc ds27 
No ligand    82 75 
4 49 >90 76 
S4-5 50 >90 76 
 
 
NMR experiments 
NMR titration experiments were performed to get information on the binding mode of 
compounds 4c and S4-5 to the G4 structures formed by the human telomeric and MYC promoter 
DNA sequences (Pagano et al., 2012). The modified telomeric sequence 
d[TTGGG(TTAGGG)3A] (Tel24) and the modified c-myc sequence 
d(TGAGGGTGGGTAGGGTGGGTAA) (myc22) were used for this study, since they give 
higher quality NMR spectra compared to the wild-type sequences, being characterized by a 
single conformation in solution (Ambrus et al., 2005; Luu et al., 2006a). The 1H-NMR spectra 
of Tel24 and myc22 well matched the ones reported in the literature, characterized by 12 well-
resolved imino protons peaks, corresponding to the 12 guanines involved in the three G-tetrad 
planes (Figures 3.26A-B) (Ambrus et al., 2005; Luu et al., 2006a). 
The investigated oligonucleotides were then titrated with 4c and S4-5, in parallel 
experiments, up to a 4:1 ligand/G4 ratio. Upon addition of increasing amounts of ligands to the 
G4 solutions, considerable proton resonance changes were observed in both imino and aromatic 
proton regions of the spectra (Figures 3.26 and 3.27), thus suggesting that both 4c and S4-5 
may not have a unique binding site. The relative line broadening observed for all the imino 
resonances and most of the aromatic ones also suggests that the ligands could explore different 
poses in the same G4 binding pocket, in fast exchange with each other. On the other hand, some 
distinct aromatic protons of both Tel24 and myc22 G4s were only weakly affected by the ligand. 
As far as 4c is concerned, for Tel24 (Figure 3.26A) this is the case of residues T6-T7-A8, 
forming the double-chain reversal loop of the G4; while for myc22 (Figure 3.26B) this is the 
case of A6, stacking on top of the 5’ G-tetrad, and of residues T10, T14-A15, and T19 
(numbering according to (Ambrus et al., 2005), which form the three double-chain reversal 
loops of the G4 structure. Regarding S4-5, the NMR titrations showed that in the interaction 
with Tel24 G4 (Figure 3.27A) the ligand affected to a lesser extent the aromatic protons of A8, 
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which is in the double-chain reversal loop, and of residues T18-T19-A20, which form a lateral 
loop close to the external G-tetrad; while in the interaction with myc22 (Figure 3.27B), the least 
affected ones were the aromatic protons of A6, which stacks on top of the 5’ G-tetrad, and of 
residues T14-A15 and T19, which form the second and third double-chain reversal loop of G4, 
respectively. 
 
 
Figure 3.26. Imino and aromatic regions of the 1H NMR spectra of (A) Tel24 and (B) myc22 G4s titrated 
with 4c. 
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Figure 3.27. Imino and aromatic regions of the 1H NMR spectra of (A) Tel24 and (B) myc22 G4s titrated 
with S4-5. 
 
Overall, these findings suggest that both 4c and S4-5 may bind these G4s mainly through 
interaction with those grooves that are not made inaccessible by the presence of loops, generally 
affecting also guanine residues involved in the three G-tetrad layers. However, our data do not 
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allow completely excluding ligand stacking on external G-tetrads, while they clearly indicate 
that loops are generally very little or not affected at all by ligand binding. 
NMR experiments helped us to further investigate the selectivity of 4c and S4-5 for G4 over 
duplex DNA. The two ligands were tested on a model duplex DNA formed by the so-called 
Dickerson sequence d(CGCGAATTCGCG) (ds12). The 1H-NMR spectrum of ds12 matched 
the one reported in the literature (Figures 3.28A-B) (Jaroszewski et al., 1996). Results of ds12 
titrations with 4c and S4-5 clearly showed that no significant variation of the chemical shift 
values of ds12 was observed upon addition of S4-5 (Figure 3.28B), up to a 4:1 ligand/DNA 
ratio, thus confirming the absence of binding with the investigated duplex DNA. On the other 
hand, 4c caused a small perturbation of the ds12 spectrum, in terms of both intensity decrease 
and line broadening of all the 1H-NMR signals (Figure 3.28B), thus suggesting the possibility 
that 4c could somehow interact in a weak and unspecific way with duplex DNA. These results 
are in full agreement with those obtained from the G4-CPG binding assays. 
 
Figure 3.28.
 1H-NMR spectra of the ds12 duplex titrated with (A) S4-5 and (B) 4c. 
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Microscale thermophoresis (MST) experiments 
To obtain quantitative data about the affinity of S4-5 for the human telomeric and MYC 
promoter G4s, MST measurements were performed. MST is a fast and easy tool to characterize 
small molecule-nucleic acid interactions in solution (Entzian and Schubert, 2016). Basically, it 
records the thermophoretic movement of a fluorescently-labeled target molecule under 
microscopic temperature gradients. This molecular motion strongly depends on changes in size, 
charge, and hydration shell. Since the binding of a ligand to the investigated molecule changes 
at least one of these parameters, it also alters the thermophoretic behavior of the target. This 
effect can be used to evaluate equilibrium constants, such as the dissociation constant Kd. To 
this purpose, serial dilutions of S4-5 were prepared, mixed with a constant concentration of 
Cy5-labeled oligonucleotides (Tel26 or myc22), loaded into capillaries and analyzed by MST. 
Experiments were run by using 8% final DMSO, in order to avoid aggregation effects observed 
in the absence of DMSO. The results of these experiments (Figure 3.29) showed that compound 
S4-5 was able to bind both Tel26 and myc22 G4s. The calculated equilibrium dissociation 
constants indicated for this ligand ca. twice higher affinity to the parallel MYC promoter G4 [Kd 
= 13 (±2) µM] than to the hybrid human telomeric G4 [Kd = 26 (±4) µM]. 
 
 
Figure 3.29. Interaction of S4-5 with (A) myc22 and (B) Tel26 G4s studied using MST experiments. (Top) 
Time traces recorded by incubating increasing concentrations of S4-5 with the labeled G4s and (bottom) 
the corresponding binding curves. 
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Molecular docking. 
To gain major insights into the binding interactions established by S4-5 with the target G4 
DNA structures, we decided to provide a theoretical model for its interaction with human 
telomeric and MYC promoter G4-forming sequences. In particular, the ligand was docked into 
the solution structures of c-myc G4 (myc22, PDB ID: 1XAV) (Ambrus et al., 2005) and into 
the hybrid-type G4 structure formed in K+ solution by the 26-mer oligonucleotide from the 
human telomere (Tel26, PDB ID: 2JPZ) (Dai et al., 2007). In this study, the software Autodock 
4.2 (AD4.2) (Cosconati et al., 2010; Morris et al., 1998) was employed, which had already been 
used for our previous virtual screening campaign to identify 4c as a G4 ligand (Cosconati et al., 
2009). 
Analysis of the results obtained when S4-5 was docked into the myc22 structure revealed 
that the ligand adopts a well-clustered binding in which the compound is inserted into the G4 
groove, unoccupied by the loop, where the ligand finds favorable van der Waals interactions 
with G21, G22, and T23 residues (Figure 3.30). This interaction is further reinforced by ionic 
interactions between the protonated nitrogen of the fused oxazine ring and the backbone 
phosphate oxygens of A24 residue. Moreover, the pendant benzyl substituent is well positioned 
to form a parallel displaced π-π interaction with G9 guanine ring. Interestingly, both the (R)- 
and the (S)-isomer of S4-5 were docked but no enantiodiscriminating binding was detected. 
Rather, the methyl substituent on the benzylic carbon seems to optimally orient the phenyl ring 
to form the aforementioned stacking interactions. Indeed, when comparing the obtained 
theoretical model with the experimental results of the NMR titrations, a good consistency is 
recorded, which gives further confidence in the viability of the obtained docking results. 
If a well-defined binding pose was detected when docking S4-5 into the myc22 solution 
structure, some difficulties were encountered when docking the ligand into the solution 
structure of the hybrid form of the human telomere DNA G4 structure. More in detail, three 
possible conformations were suggested by the docking software in which the ligand always 
occupies the available groove between the first and fourth strand of the G4 structure (Figure 
3.31). 
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Figure 3.30. Binding mode of S4-5 when docked into the c-myc G4 DNA solution structure. The ligand is 
represented as grey sticks while the DNA as dark cyan ribbons and sticks. H-bonds are represented as 
dashed yellow lines. DNA residues were numbered according to Ambrus, A. et al.(Ambrus et al., 2005). 
 
In these three conformations, the ligand adopts the same orientation with respect to the G4 
but at different levels of the groove, one towards the 3’ end (herein referred to as pose A), one 
in the middle (herein referred to as pose B), and one towards the 5’ end (herein referred to as 
pose C). In pose A, the ligand establishes a H-bond, through its furan oxygen, with the NH2 
group of G24, and an ionic interaction, through its protonated oxazine nitrogen, with the T25 
phosphate group. In pose B, a clear H-bond is formed between the ligand furan oxygen and the 
G23 NH2 group. In pose C, one of the two ligand quinone oxygens forms a H-bond with the 
NH2 group of the G4 and a charged reinforced H-bond through its protonated oxazine nitrogen 
and the sugar O4’ atom of G22. Moreover, the phenyl ring of the ligand benzyl moiety forms 
parallel displaced π-π interactions with A3 and G22 aromatic rings. Regardless of their 
positions in all the three conformations (A, B, and C) the ligand forms van der Waals contacts 
with the groove atoms of the G4 structure. Moreover, as observed for the myc22 structure, also 
for Tel26 no enantiodiscriminating binding was detected. From the above-described docking 
results, we cannot give a preference for one of the obtained solutions; rather, it is possible to 
speculate that the ligand is able to slide into the G4 groove adopting almost isoenergetic binding 
conformations. This might corroborate the results of the NMR titration experiments, which 
were not helpful in indicating a specific binding region.  
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Figure 3.31. Alternative binding poses predicted for S4-5 when docked into the tel26 solution structure. The 
ligand is represented as grey sticks, the DNA as magenta ribbons and sticks. H-bonds are represented by 
dashed yellow lines. 
 
3.3.3 Conclusions 
In the last decade, increasing efforts in the G4 research field have been devoted to the search 
of specific G4-binders, able to recognize G4s with high affinity, fully discriminating G4 vs. 
duplex DNA. Considering the wide distribution and variety of G4 structures within the human 
genome and their recognized roles in several cancer-related processes, these G4 binders could 
result into effective multi-target ligands, and expectedly into useful anticancer drugs with 
almost null side effects. To reach this ambitious goal, an integrated approach is required, 
involving the massive production of large libraries of new putative G4 ligands, coupled with 
High Throughput Screening methodologies for the fast and reliable analysis of the selected 
compounds. In this perspective – which is basically inspired to combinatorial approaches for 
drug discovery – detailed biophysical characterization studies are carried out only after the 
biological assays, thus devoted only to the best performing G4-ligands, which, following 
iterative optimization steps, may finally result into promising candidate drugs. 
In this work, we have analyzed a focused library of commercially available analogs of a 
well-characterized G4-binder, here used as a hit compound, differing for the nature of the 
pendant groups attached on the N-atom of the oxazine ring. The main idea was to explore the 
effects of a single diversity element inserted on a common planar scaffold, which per se acts as 
a suitable structural motif for G4 recognition. From a methodological point of view, we also 
aimed at providing a useful working model, here developed as a proof-of-concept, in which our 
